Substance Abuse (F1)

Misuse Of Alcohol And Alcohol-related Disorders

Misuse of alcohol encompasses a spectrum of maladaptive drinking behaviors ranging from hazardous consumption to alcohol dependence, leading to physical, psychological, and social harm including liver disease, neuropsychiatric disorders, and withdrawal syndromes.

Exam domainOne-glance essentials
Definition / diagnosis
  • Alcohol-use disorder is impaired control and continued use despite harm [1]
  • Intoxication, withdrawal and organ disease form a broad clinical spectrum [1]
Epidemiology / risks
  • Family history, trauma, psychiatric illness and social availability increase risk [1]
  • Tolerance and prior withdrawal predict dependence severity [1]
Core mechanism
  • Alcohol enhances GABA and inhibits NMDA; chronic use produces adaptation [1]
  • Abrupt cessation then causes autonomic and excitatory withdrawal [1]
Clinical picture
  • Loss of control, morning drinking, blackouts and social harm [1]
  • Tremor, sweating, hallucinations, seizures or delirium tremens signal withdrawal [1]
Investigations
  • Quantify use and last drink; assess withdrawal score, glucose, electrolytes and liver injury [2]
  • Screen nutrition, suicide risk and other substances [2]
Management
  • Give thiamine before or with glucose when deficiency is possible [3]
  • Benzodiazepines treat significant withdrawal; relapse prevention combines psychosocial and medication options [3]
Complications
  • Seizures, delirium tremens, Wernicke-Korsakoff syndrome and liver disease [4]
  • Trauma, cancer, cardiomyopathy and suicide add major mortality [4]
Prevention / follow-up
  • Brief intervention and lower-risk drinking advice help before dependence develops [3]
  • Relapse plans, mutual help and medication reduce recurrence [3]
Exam traps
  • Do not give glucose alone to a thiamine-deficient patient [2]
  • Withdrawal can be severe even when blood alcohol remains detectable [3]

References

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p2, p42–p46)

[2] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p2, p4–5, p7, p19, p38, p42–43)

[3] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p10, p12, p14, p38, p40–41, p44)

[4] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p12, p14, p24, p28, p34, p36–44, p48)

Alcohol misuse refers to a spectrum of maladaptive patterns of alcohol consumption that cause clinically significant impairment or distress. The terminology has evolved over time:

  • Alcohol Use Disorder (AUD) — the current DSM-5 unified term (replacing the older DSM-IV dichotomy of "alcohol abuse" vs "alcohol dependence") [1]
  • Harmful use — ICD-10 term for a pattern of drinking causing damage to physical or mental health
  • Dependence syndrome — ICD-10/ICD-11 term describing a cluster of physiological, behavioural, and cognitive phenomena (tolerance, withdrawal, compulsion, loss of control, continued use despite harm, neglect of other activities)
  • Alcoholism — a colloquial, non-diagnostic term still widely used clinically

Breaking down the key term: "alcohol" derives from Arabic al-kuḥl (originally meaning a fine powder, later applied to distilled spirits); "misuse" implies a pattern beyond social/recreational use that leads to harm.

Spectrum of Alcohol Use

Think of alcohol problems as a continuum: social drinking → hazardous drinking (at-risk but no current harm) → harmful drinking (demonstrable damage) → alcohol dependence (physiological and psychological reliance). A patient can sit anywhere on this spectrum, and movement is bidirectional.


Epidemiology

  • Alcohol is the 7th leading risk factor for death and disability globally (GBD 2016 data, confirmed in 2019 updates)
  • Contributes to > 3 million deaths/year (5.3% of all deaths worldwide) — WHO Global Status Report on Alcohol and Health
  • Responsible for > 200 disease and injury conditions
  • Heavy episodic drinking (binge drinking) prevalence ~18.2% globally among drinkers

These HK-specific figures are frequently tested.

  • 23.7% drank alcohol occasionally, 9.4% at least once/week, 61.6% non-drinkers [2]
  • 66.5% usually drink beer, 19.6% table wine, 10.6% Chinese rice wine, 6.9% spirits [2]
  • Among drinkers, M:F ≈ 2:1; 7.2% were binge drinkers [2]
  • 16.9% reported drinking beyond daily limit. 5.8% exhibited signs of drunkenness [2]
  • Alcohol-related deaths contributed to 0.14% of deaths (58 in 2009) [2]

  • Males consistently have higher rates of AUD (2–3× females) — this gap is narrowing in younger cohorts
  • Peak onset of AUD: late teens to mid-20s
  • Women develop alcohol-related organ damage (liver, brain, cardiomyopathy) at lower cumulative doses and shorter durations than men — the so-called "telescoping effect"

Why are women more susceptible? Two key reasons [2]:

  1. Lower total body water (proportionally more adipose tissue) → higher blood alcohol concentration (BAC) for the same dose per kg
  2. Lower gastric alcohol dehydrogenase (ADH) activity → less first-pass metabolism → more ethanol reaches systemic circulation

Risk Factors

Biological Factors

  • Genetic predisposition plays a substantial role (heritability ≈ 50%) [2]
  • Family/twin studies: MZ > DZ concordance rate, ↑ in adopted descendants of alcoholics [2]
  • Cloninger subtypes: [2]
    • Cloninger Type 1: later age of onset, only mildly genetic, occurs in both M + F, associated with anxious/harm-avoidant personality
    • Cloninger Type 2: earlier age of onset, strongly genetic, occurs predominantly in M, associated with criminality and sociopathic disorder, novelty-seeking personality
  • Key genes include: [2]
    • Alcohol metabolism enzymes: ALDH2 (aldehyde dehydrogenase) inactivating mutation — much more common in Asians and associated with ↓ risk of alcohol dependence [2] — this is the so-called "Asian flush" variant (ALDH2*2), which causes accumulation of acetaldehyde → flushing, nausea, tachycardia after drinking → acts as a protective factor
    • Neurotransmitter-related: GABRG1, GABRA2 (GABA_A receptor genes), COMT, DRD2 (dopamine D₂ receptor) [2]

ALDH2*2 — Hong Kong High Yield

About 30–40% of East Asians carry the ALDH22 allele. Homozygotes (ALDH22/2) almost never become alcoholics because the aversive acetaldehyde reaction is so severe. Heterozygotes have intermediate risk. This is why disulfiram works — it pharmacologically mimics what ALDH22 does genetically. However, note that ALDH2*2 carriers who DO drink are at higher risk of oesophageal and head/neck cancers (acetaldehyde is a carcinogen).

  • Some biological abnormalities found to predate and predict later alcohol misuse: [2]
    • ↓ Cognitive performance in some aspects, e.g. executive function, abnormal P300 visual evoked potential (VEP) [2]
    • ↓ Sensitivity to acute intoxication effects of alcohol [2] — paradoxically, individuals who need more alcohol to "feel drunk" are at higher risk because they consume more before experiencing negative feedback

Psychological Factors [2]

  • Associated personalities include: [2]
    • Chronic anxiety, pervading sense of inferiority, self-indulgent tendencies
    • Traits related to risk-taking and novelty-seeking, antisocial personality disorder

  • Behaviour modelling: postulated that children of alcoholics model their behaviour on parents, but the risk seems little influenced by whether parents are currently drinking or not [2]
  • Reward dependence: alcohol use leads to ↑ pleasurable feelings and ↓ anxiety → behavioural reinforcement, especially in those who ignore negative consequences (positive and negative reinforcement via the mesolimbic dopamine pathway) [2]

Social Factors [2]

  • Childhood exposure to potentially traumatic events, especially emotional abuse [2]
  • Other environmental factors: family disruption, poverty, social isolation [2]

  • Alcohol use can be a cause or effect of other psychiatric disorders [2]
    • Chronic alcohol use can precede development of major psychiatric disorders (e.g. mood disorders, psychotic disorders)
    • Alcohol use can be a maladaptive response (self-medication) to ↓ distress from other psychiatric disorders

  • Availability and affordability of alcohol (HK: relatively cheap, 24-hour availability in convenience stores)
  • Cultural norms (drinking at business dinners, social gatherings)
  • Peer pressure, social circle influence
  • Occupation — high-risk occupations include hospitality, military, medical profession (access + stress)

Anatomy, Physiology, and Pharmacology of Alcohol

Understanding metabolism is critical because it underpins intoxication, withdrawal, organ damage, and drug interactions.

Step 1: Ethanol → Acetaldehyde

  • Enzyme: Alcohol dehydrogenase (ADH) — primarily in gastric mucosa and hepatocytes
  • Cofactor: NAD⁺ → reduced to NADH
  • Also via Microsomal Ethanol Oxidizing System (MEOS/CYP2E1) — inducible with chronic use (explains metabolic tolerance)
  • Also via catalase (minor pathway, in peroxisomes)

Step 2: Acetaldehyde → Acetate

  • Enzyme: Aldehyde dehydrogenase (ALDH) — primarily mitochondrial ALDH2
  • Cofactor: NAD⁺ → NADH
  • Acetaldehyde is toxic and carcinogenic — responsible for the "flush reaction," hangover symptoms, and long-term tissue damage

Step 3: Acetate → CO₂ + H₂O

  • Acetate enters peripheral tissues, converted to acetyl-CoA → enters TCA cycle

Key metabolic consequence: Chronic ethanol metabolism massively shifts the hepatic NAD⁺/NADH ratio toward NADH. This has widespread metabolic consequences:

  • ↓ Gluconeogenesis → alcoholic hypoglycaemia (occurs 6–36h after ingestion of > 30g alcohol) [2]
  • ↓ Fatty acid oxidation → fatty liver (steatosis)
  • ↑ Lactate (pyruvate → lactate is favoured) → lactic acidosis
  • ↑ Uric acid (lactate competes with urate for renal excretion) → gout

Alcohol is fundamentally a CNS depressant that acts on multiple neurotransmitter systems:

SystemAcute Effect of AlcoholChronic AdaptationRelevance to Withdrawal
GABA-A↑ GABA-ergic (inhibitory) neurotransmission — potentiates GABA at GABA-A receptors [2]Downregulation of GABA-A receptors (tolerance)↓ GABA-related inhibitory tone → hyperexcitability [2]
NMDA (glutamate)Inhibition of glutamatergic (excitatory) neurotransmission via NMDA receptor blockade [2]Upregulation of NMDA receptors [2]Unregulated excess NMDA-related excitatory transmission [2] → seizures, autonomic storm
Dopamine↑ DA release in mesolimbic pathway (nucleus accumbens) → pleasurable effect [2]Downregulation of DA receptorsDysphoria, anhedonia, craving
SerotoninIndirectly alters release of serotonin [2]Serotonergic dysfunctionMood disturbance, anxiety
Opioid↑ Endogenous opioid (endorphin) releaseOpioid system dysregulationDysphoria
NorepinephrineIndirectly alters release of NE [2]Upregulation of adrenergic systemAutonomic hyperactivity (tremor, sweating, tachycardia, hypertension)

The GABA-Glutamate Seesaw — Core Concept

Think of the brain as a seesaw between inhibition (GABA) and excitation (glutamate/NMDA). Alcohol acutely pushes the seesaw toward inhibition. With chronic use, the brain compensates by reducing GABA sensitivity and increasing NMDA receptors (trying to restore balance). When alcohol is suddenly removed, the seesaw swings violently toward excitation — this is why withdrawal causes tremors, seizures, and delirium tremens. This is the single most important concept in alcohol withdrawal pathophysiology.

  • In HK, 1 unit of alcohol = 10g pure ethanol [2]
  • Number of standard drinks = drink volume (L) × alcohol content (%vol) × 0.789 [2]
    • The 0.789 factor accounts for the density of ethanol (0.789 g/mL)
  • Safe drinking limit = 2 units/day (M) vs 1 unit/day (F) [2]

Practical unit estimates [2]:

DrinkApproximate Units
1 can of beer (330 mL, 5%)1.3 units
1 glass of wine (125 mL, 12%)1.2 units
1 shot of spirits (22 mL, 40%)0.7 units
1 small glass of rice wine (20 mL, 30%)0.6 units

Blood Alcohol Concentration (BAC):

  • 0.1 mg/L on breathalyser corresponds to 21 mg/dL in blood [2]
  • BAC of 5 mg/dL (22 µg/100 mL on breathalyser) is the driving limit in HK [2]

The aetiology of alcohol misuse is biopsychosocial — it arises from an interaction of biological vulnerability, psychological factors, and social environment [2]. No single factor is sufficient or necessary; it is the convergence of multiple factors that determines risk.

Neurobiological Basis of Addiction

The core mechanism of alcohol addiction involves the mesolimbic dopamine (reward) pathway:

  1. Ventral tegmental area (VTA) → projects dopaminergic neurons to the nucleus accumbens (NAc)
  2. Alcohol (and other substances) increase dopamine release in the NAc → subjective pleasure/reward
  3. With repeated exposure, neuroadaptation occurs:
    • Tolerance — need more alcohol for the same reward (GABA-A downregulation, NMDA upregulation, CYP2E1 induction)
    • Sensitisation of incentive-salience pathways — environmental cues associated with alcohol become powerfully motivating
    • Negative reinforcement — drinking to avoid withdrawal becomes a dominant driver
  4. Prefrontal cortex (executive control) is progressively impaired → loss of inhibitory control over drinking behaviour

Alcoholism affects the brain front (frontal dementia), back (cerebellar vermis) and centre (corpus callosum) [2] — this elegant summary reminds us that chronic alcohol causes:

  • Frontal lobe atrophy → executive dysfunction, disinhibition, personality change
  • Cerebellar vermis degeneration → gait ataxia (heel-shin test abnormal > finger-nose test)
  • Corpus callosum degeneration (Marchiafava-Bignami disease) → disconnection syndrome

Classification

  1. Episode of harmful use of alcohol — single episode causing damage
  2. Harmful pattern of use of alcohol — repeated pattern causing damage
  3. Alcohol dependence — chronic relapsing condition with compulsion, tolerance, withdrawal
  4. Alcohol intoxication — acute reversible syndrome
  5. Alcohol withdrawal — physiological syndrome upon cessation/reduction
  6. Alcohol-induced disorders — e.g. alcohol-induced mood disorder, psychotic disorder, neurocognitive disorder

  • Alcohol Use Disorder (AUD) — mild (2–3 criteria), moderate (4–5 criteria), severe (6+ criteria out of 11)
  • Alcohol intoxication
  • Alcohol withdrawal
  • Alcohol-induced mental disorders (specify type: depressive, anxiety, psychotic, sleep, sexual dysfunction, neurocognitive)

FeatureType 1Type 2
Age of onsetLaterEarlier (before 25)
Genetic influenceMildly geneticStrongly genetic
SexBoth M + FPredominantly M
PersonalityHarm-avoidant, anxiousNovelty-seeking, a/w criminality and sociopathic disorder
Alcohol-seeking behaviourLoss of controlInability to abstain
Environmental influenceStrongWeak

Clinical Features

The clinical features of alcohol misuse can be organised into:

  • A. Acute intoxication
  • B. Chronic use features (symptoms and signs of dependence)
  • C. Withdrawal syndrome
  • D. Long-term medical sequelae
  • E. Long-term psychiatric sequelae

A. Acute Alcohol Intoxication

Clinical features are dose-dependent and relate to BAC:

BAC (mg/dL)Clinical FeaturesPathophysiological Basis
20–50Relaxation, mild euphoria, ↓ inhibitionsPotentiation of GABA-A in limbic system → ↓ cortical inhibition of reward pathways
50–100Impaired coordination, ↓ reaction time, emotional labilityGABA-A potentiation + NMDA inhibition in cerebellum and motor cortex
100–200Slurred speech, ataxia, diplopia, nausea/vomitingProgressive cerebellar and brainstem depression
200–300Marked ataxia, hypothermia, severe dysarthriaBrainstem depression, impaired thermoregulation
300–400Stupor, comaSevere generalised CNS depression
> 400Respiratory depression, deathMedullary respiratory centre depression

Note: Tolerant individuals may show surprisingly few signs at BAC levels that would incapacitate a naive drinker. No intoxication despite ↑↑BAC can denote development of tolerance [2].

Alcoholic blackouts [2]:

  • S/S: a transient amnesia lasting hours, but usually without impairment of conscious level [2]
  • Reason: inhibition of NMDA receptors in hippocampus → failure of long-term potentiation (LTP) [2]
  • The hippocampus requires NMDA receptor activation to consolidate short-term into long-term memories; alcohol blocks this

Alcoholic hypoglycaemia [2]:

  • Occurs 6–36h after ingestion of > 30g of alcohol (moderate amount) [2]
  • MoA: alcohol metabolism into acetaldehyde consumes NAD⁺ → ↑↑↑ NADH:NAD⁺ ratio in liver → insufficient NAD⁺ supply for gluconeogenesis → hypoglycaemia [2]
  • S/S: confusion, aggression, stupor, coma, hypothermia → often mistaken as alcohol intoxication [2]
  • Dx: hypoglycaemia is an important d/dx in confused patient with prior alcohol intake → should take H'stix before assuming intoxication [2]
  • Mx: IV 50% dextrose after thiamine [2]

  • Primarily supportive [2]
  • IV fluid hydration to correct volume depletion and hypotension [2]
  • D50 infusion if hypoglycaemia is present [2]
  • 100 mg parenteral thiamine mandatory if present with coma (for prevention of B₁ deficiency) [2]
  • 'Thiamine before dextrose': traditional teaching that thiamine should be given before dextrose [2]
    • Basis: theoretically, glucose loading in a thiamine-deficient cell may result in lactic acidosis as the TCA cycle fails to work in thiamine-deficient environment [2]
    • Evidence: weak, likely NOT evidence-based → thiamine can be given together with dextrose [2]
  • Benzodiazepines or first-generation antipsychotics (FGA) can be used if agitated [2]

Common Exam Mistake

Never assume a "drunk" patient is simply intoxicated. Always check blood glucose (H'stix), because alcoholic hypoglycaemia closely mimics intoxication (confusion, aggression, hypothermia). Missing hypoglycaemia can be fatal. Also consider: subdural haematoma, hepatic encephalopathy, Wernicke encephalopathy, and head injury — all common in alcoholics and all mimicking intoxication.

The ICD-10/ICD-11 dependence syndrome requires 3 or more of the following in the past 12 months. DSM-5 AUD uses a single list of 11 criteria (≥ 2 for diagnosis). The core features and their pathophysiology:

FeatureExplanationPathophysiology
Compulsion/cravingStrong desire or sense of compulsion to drinkSensitisation of incentive-salience in mesolimbic DA pathway; conditioned cue-reactivity
Difficulty in controlling useOnset, termination, or amount of drinkingPrefrontal cortical dysfunction → impaired executive control; habit formation in dorsal striatum
ToleranceNeed for increasing amounts to achieve same effectGABA-A receptor downregulation, NMDA receptor upregulation, CYP2E1 induction (metabolic tolerance)
WithdrawalPhysical symptoms on cessation/reductionGABA-glutamate imbalance: ↓ GABAergic inhibition + ↑ NMDA excitatory transmission
Neglect of other activitiesProgressive neglect of alternative pleasures or interestsReward system "hijacked" — natural rewards pale compared to drug-induced DA surges
Persistent use despite harmful consequencesContinued drinking despite awareness of physical, psychological, or social harmCompulsive behaviour loop; impaired prefrontal insight and decision-making
Stereotyped patternNarrowing of drinking repertoireFixed drinking patterns emerge as the behaviour becomes habitual

C. Withdrawal Syndrome [2]

  • Impact of chronic use: insensitivity to GABA + upregulation of NMDA receptors [2]
  • Withdrawal: ↓ GABA-related inhibitory tone + unregulated excess NMDA-related excitatory transmission [2]
  • This produces a state of CNS hyperexcitability — explaining every feature of withdrawal

Symptoms of alcohol withdrawal vary with individual (?genetic predisposition) [2]:

Time After Last DrinkFeaturePathophysiology
6–12 hoursTremor, anxiety, nausea, insomnia, sweating, tachycardiaNoradrenergic and glutamatergic overactivity; ↓ GABAergic tone
12–24 hoursAlcoholic hallucinosis (visual/auditory hallucinations with clear sensorium)Cortical hyperexcitability (NMDA upregulation) without global confusion
12–48 hoursWithdrawal seizures (generalised tonic-clonic)NMDA hyperexcitability + loss of GABA-mediated seizure threshold; often in patients with "kindling" from repeated withdrawals
48–72 hoursDelirium Tremens (DT) — the most severe formFull-blown excitotoxic state with autonomic storm

  • Onset: typically 48–72 hours (but can occur up to 5–7 days) after last drink
  • Classic triad: Confusion (delirium with fluctuating consciousness), Tremor (coarse), Autonomic hyperactivity (fever, sweating, tachycardia, hypertension)
  • Other features: vivid visual hallucinations (classically small animals/insects — "Lilliputian hallucinations"), paranoid ideation, agitation, insomnia
  • Mortality: 5–15% untreated (historically up to 35%); < 1–2% with modern ICU care
  • Risk factors for DT: previous DT/withdrawal seizures, comorbid illness, older age, heavy prolonged drinking, high BAC at presentation, electrolyte abnormalities
  • Kindling effect: each successive withdrawal episode tends to be more severe than the last — NMDA receptor upregulation becomes progressively more exaggerated with repeated withdrawal-reinstatement cycles

Chronic alcohol causes damage through multiple mechanisms:

  1. Direct toxicity (ethanol and acetaldehyde are directly cytotoxic)
  2. Nutritional deficiency (B1/thiamine, B3/niacin, B6, B12, folate, zinc, magnesium)
  3. Metabolic disruption (NAD⁺/NADH ratio, oxidative stress, lipid metabolism)
  4. Immune dysregulation (↓ immune function → infections)
SystemConditionMechanism
LiverSteatosis → Steatohepatitis → Fibrosis → Cirrhosis → HCCShifted NAD⁺/NADH ratio → ↓ fatty acid oxidation → fat accumulation; acetaldehyde-protein adducts → immune-mediated hepatocyte injury; stellate cell activation → collagen deposition
GIOesophageal varices, Mallory-Weiss tears, gastritis/peptic ulcer, pancreatitis (acute and chronic), oesophageal carcinomaPortal hypertension (varices); direct mucosal irritation (gastritis); acetaldehyde is a group 1 carcinogen (oesophageal Ca); pancreatic duct protein plugging → calcification
CVSAlcoholic cardiomyopathy (dilated), AF, hypertensionDirect myocardial toxicity (acetaldehyde); holiday heart (binge → AF due to autonomic surge and direct electrophysiological effects); chronic sympathetic activation
HaemMacrocytosis (↑MCV), folate deficiency megaloblastic anaemia, sideroblastic anaemia, thrombocytopenia, leucopeniaFolate malabsorption/↓intake → megaloblastic change; direct marrow suppression; ↑MCV also from direct membrane effect of ethanol on erythroblasts
EndocrinePseudo-Cushing syndrome, hypogonadism (gynaecomastia, testicular atrophy), hypoglycaemia↑ CRH/cortisol; ↑ aromatisation of androgens → oestrogens in liver + direct gonadal toxicity; ↓ NAD⁺ for gluconeogenesis
MSKMyopathy, osteoporosis, goutDirect myotoxicity; ↓ osteoblast activity + ↑ osteoclast activity; ↑ uric acid (lactate competes for renal tubular excretion)
NeurologicalSee below (major section)Multiple mechanisms — direct toxicity, nutritional deficiency, excitotoxicity

Neurological Complications (High Yield — "6 Causes of Confusion in Alcoholism") [1]

The lecture specifically highlights "6 causes of confusion in alcoholism" [1] — this is a critical exam framework:

  1. Acute intoxication — GABA potentiation, NMDA blockade
  2. Alcohol withdrawal / Delirium Tremens — GABA/NMDA imbalance → excitotoxicity
  3. Wernicke encephalopathy — thiamine (B1) deficiency → impaired glucose metabolism in vulnerable brain regions (mamillary bodies, medial thalamus, periaqueductal grey, cerebellar vermis)
  4. Hepatic encephalopathy — ↑ ammonia (failed hepatic metabolism in cirrhosis) → astrocyte swelling, altered neurotransmission
  5. Hypoglycaemia — ↓ NAD⁺ for gluconeogenesis
  6. Subdural haematoma — falls + coagulopathy (↓ clotting factors from hepatic dysfunction + thrombocytopenia) → bridging vein tears

Wernicke-Korsakoff Syndrome — the hallmark nutritional neuropsychiatric complication:

  • Wernicke encephalopathy (acute, reversible if treated early):

    • Classic triad: Confusion, Ophthalmoplegia (especially CN VI palsy → lateral rectus paralysis → diplopia), Ataxia (cerebellar vermis degeneration)
    • Why these areas? Thiamine (as thiamine pyrophosphate, TPP) is a cofactor for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase — areas with high metabolic demand and turnover (periventricular structures) are most vulnerable to energy failure
    • Only ~10% present with the classic triad — have a low threshold for diagnosis
    • Treatment: IV thiamine 500 mg TDS for 3 days (high-dose Pabrinex) — must be given before or with glucose
  • Korsakoff syndrome (chronic, largely irreversible):

    • Develops in ~80% of untreated Wernicke patients
    • Profound anterograde amnesia (inability to form new memories) + retrograde amnesia (loss of old memories, with temporal gradient)
    • Confabulation — production of fabricated memories to fill gaps (not intentional lying; the brain's attempt to make sense of memory gaps)
    • Why? Damage to mamillary bodies and medial thalamic nuclei — key structures in the Papez circuit of memory
    • Only ~20% recover significantly even with thiamine supplementation

Other key neurological complications:

ConditionFeaturesMechanism
Cerebellar degenerationGait ataxia (wide-based), heel-shin test abnormal > finger-nose; truncal > limb ataxiaPurkinje cell loss in anterior superior vermis — combination of direct ethanol toxicity and thiamine deficiency
Peripheral neuropathySymmetric distal sensorimotor ("stocking-glove"), painful paraesthesiae, ↓ ankle jerksDirect neurotoxicity + B-vitamin deficiency (B1, B6, B12) → axonal degeneration (dying-back neuropathy)
Central pontine myelinolysis (CPM)Quadriparesis, pseudobulbar palsy, "locked-in" syndromeOverly rapid correction of hyponatraemia → osmotic stress on oligodendrocytes in basis pontis → demyelination
Marchiafava-Bignami diseaseDisconnection syndrome, seizures, cognitive declineDemyelination/necrosis of corpus callosum — mechanism unclear, likely direct toxicity + nutritional deficiency
Alcohol-tobacco amblyopia [2]↓ VA with central scotoma and loss of colour visionHeavy drinking + smoking → deficiency of thiamine or B12 → optic atrophy
Alcoholic dementiaProgressive cognitive decline, frontal predominance (executive dysfunction, personality change)Multifactorial: direct neurotoxicity, repeated excitotoxic episodes (withdrawals), nutritional deficiency, vascular risk

Never Correct Hyponatraemia Too Quickly

Never correct hyponatraemia quicker than ~10 mmol/24h [2] in an alcoholic patient. Rapid correction → osmotic demyelination syndrome (central pontine myelinolysis). The pons is particularly susceptible because of its unique vascular architecture and high oligodendrocyte density. This is irreversible and devastating.

Psychiatric comorbidity in alcoholism is very common (lifetime diagnosis occurs in 55% of alcoholics) [2]

Causation: alcoholism often co-occurs with psychiatric disorders but causation is often unclear [2]

The relationship is bidirectional, with confounding factors [1]:

  • Alcoholism → Psychiatric symptoms (alcohol-induced disorders)
  • Psychiatric symptoms → Alcoholism (self-medication)
  • Confounding factors complicate the picture [1]

Diagnosing comorbid psychiatric disorder in alcoholics is supported by [1][2]:

  • Evidence of psychiatric disorder before onset of alcohol abuse or dependence [1]
  • Evidence of persistent psychiatric symptoms during extended alcohol-free periods (over 4 weeks) [1]
  • First-degree biological relative has documented psychiatric disorder [1]

Specific Comorbidities [1][2]

ComorbidityPrevalenceKey Points
Mood disorders40% of alcoholics [2]Depression: most common comorbidity; alcoholism may be self-medication. 4× risk of major depression in patients with Hx of alcohol dependence [2]
Bipolar I disorder60% of bipolar I patients have alcoholism [1]Manic episodes → hyperexcitability and impulsivity → ↑ alcohol intake. Alcoholism aggravates bipolar disorder and a/w ↑ suicide rate [2]
Antisocial personality14% of alcoholics, but 80% of antisocial personality patients suffer from alcoholism [1]Strong bidirectional association
Schizophrenia30% abuse alcohol [1]Alcohol ↓ feeling of isolation and temporarily ↓ symptoms of anxiety/depression/insomnia. BUT ↑ psychotic symptoms and mood swings, disruptive behaviour, suicide, treatment non-compliance, drug abuse, poor clinical outcome, drug accumulation due to hepatic damage [1]
Anxiety disorders32% of alcoholics [2]May be self-medication (anxiolytic effect). Must be distinguished from alcohol withdrawal syndrome [2]
Drug abuse20% of drug abusers are alcoholic; alcoholics are 6× more prone to become drug abusers [1]Cross-reinforcement through shared dopaminergic pathways

Alcohol-related mood disorders [2]:

  • Moderate/heavy alcohol use can cause mood disorders
  • Major depression: 4× risk in patients with Hx of alcohol dependence [2]
  • Rarely easy to untangle cause and effect between mood disorder and alcoholism [2]
  • Response to treatment is much less likely if comorbid alcoholism is NOT dealt with [2]
  • Mx: abstinence (clears up upon abstinence but may persist for up to 4 weeks afterwards) [2]

Alcohol-related anxiety disorders [2]:

  • Any form of anxiety (GAD, phobic anxiety, OCD…) while on heavy alcohol consumption [2]
  • Must be distinguished from alcohol withdrawal syndrome [2]
  • Mx: abstinence (subside gradually, but may persist up to 6 months) [2]

Approach to Potential Alcohol Misuse [2]

Alert to potential alcohol misuse in the following situations [2]:

  • General: issues with ADL, family/work, finances, law (especially if frequent absences on Monday — because weekend binge → Monday withdrawal/hangover)
  • Medical: intoxication, withdrawal, other medical consequences of alcohol
  • Psychiatric: anxiety, depression, erratic moods, ↓ concentration/memory lapses, DSH/suicide

ToolDetails
CAGE questionnaire↑ Sensitivity but modest specificity only [2]. 4 questions: Cut down, Annoyed by criticism, Guilty, Eye-opener (morning drink). ≥ 2 positive = screen positive.
AUDIT (Alcohol Use Disorders Identification Test)↑ Sensitivity + ↑ Specificity, probably most useful [2]. 10-item screening tool by WHO [2]. Covers consumption, dependence symptoms, and alcohol-related problems. Score ≥ 8 = hazardous drinking.

A comprehensive drinking history should include [2]:

  • Initiation: reason for drinking, triggers, when did daily drinking start
  • Use: current, regular, maximal use, describe a typical day (especially note time of first drink — an early morning drink strongly suggests dependence/relief drinking)
  • Signs/symptoms of dependence: compulsion/craving, difficulty in control behaviour, stereotyped behaviour, tolerance, withdrawal, persistent use despite negative consequences, neglect of other interests and activities
  • Impact: physical, mental health, ADL, family, work, social relationships
  • Quitting: dates and reasons of abstinence, dates and reasons of relapses, attitude

Laboratory features of chronic alcoholism include [2]:

TestSensitivityKey Points
↑ GGT70%Useful screening tool but non-specific, dose-related [2]. Also elevated in liver disease of any cause, obesity, medications (e.g. anticonvulsants). Normalises within 2–6 weeks of abstinence.
↑ MCV60%More commonly in females; strong indicator of excessive drinking (once rule out other causes); takes weeks to return to baseline after abstinence [2]. Other causes: B12/folate deficiency, hypothyroidism, liver disease, myelodysplastic syndrome.
↑ CDT (carbohydrate-deficient transferrin)VariableMore specific than GGT [2]. Ethanol interferes with glycosylation of transferrin. Particularly useful for monitoring relapse.
Breath/blood alcohol concentrationN/AOnly reflects current drinking [2]. Useful for acute management but not for detecting chronic misuse.
Other-LFTs (AST:ALT ratio > 2:1 is classic for alcoholic liver disease — because mitochondrial AST is released preferentially); FBC (↑MCV, ↓platelets); U&E (↓K⁺, ↓Mg²⁺, ↓PO₄³⁻); lipid profile; uric acid

The lecture on "Alcohol and the Brain" covers [1]:

  • Alcohol-related addictive problems
  • Alcohol-related medical conditions and brain changes
  • Alcohol-related psychiatric disorders (alcohol-induced psychiatric disorders and comorbid conditions)
  • Relationship between alcohol and psychiatric disorders
  • 6 causes of confusion in alcoholism

High Yield Summary

Key Concepts:

  1. 1 unit in HK = 10g pure ethanol; safe limits = 2 units/day (M), 1 unit/day (F)
  2. Neuropharmacology: Alcohol = GABA-A potentiator + NMDA inhibitor + ↑ mesolimbic DA. Chronic use → GABA-A downregulation + NMDA upregulation. Withdrawal = excitotoxic state.
  3. ALDH2*2 mutation is common in Asians → protective against alcoholism (flush reaction) but ↑ cancer risk if they do drink
  4. Cloninger Type 1 (later onset, both sexes, mild genetics) vs Type 2 (early onset, male, strong genetics, antisocial)
  5. Withdrawal timeline: Tremor (6–12h) → Hallucinosis (12–24h) → Seizures (12–48h) → DT (48–72h). Each successive withdrawal is worse (kindling).
  6. Wernicke triad: Confusion + Ophthalmoplegia + Ataxia. Give IV thiamine BEFORE or WITH glucose. Only 10% have full triad — maintain a low threshold.
  7. Korsakoff: Anterograde amnesia + confabulation. Mamillary bodies + medial thalamus damage. Largely irreversible.
  8. 6 causes of confusion in alcoholism: Intoxication, Withdrawal/DT, Wernicke, Hepatic encephalopathy, Hypoglycaemia, Subdural haematoma
  9. Psychiatric comorbidity in 55% of alcoholics: Depression (40%), Bipolar I (60% of bipolar patients), Antisocial PD (80% of ASPD patients), Schizophrenia (30%), Anxiety (32%)
  10. Diagnosing comorbid psych disorder: psychiatric disorder before alcohol onset, persistent symptoms during ≥ 4 weeks alcohol-free, FHx of psychiatric disorder
  11. Screening: AUDIT (best — ↑ sensitivity + specificity, 10-item WHO tool) > CAGE (↑ sensitivity only)
  12. Lab markers: ↑GGT (70%, non-specific), ↑MCV (60%, weeks to normalise), ↑CDT (most specific)

Active Recall - Alcohol Misuse and Alcohol-related Disorders

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p2, p42–p46) [2] Senior notes: ryanho-psych.md (sections 5.1, 5.1.1; pages 96–109) [3] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (general content on neuropharmacology and aetiology)

The differential diagnosis in alcohol-related disorders is not a single, neat list — it varies depending on which clinical presentation brings the patient to attention. A patient with alcohol problems can present with intoxication, withdrawal, confusion, psychosis, mood disturbance, anxiety, or cognitive decline. For each presentation, the differential is different. Let's walk through this systematically.


The key clinical question is: "What am I actually seeing — and what else could cause this?"


This is arguably the most high-yield differential in alcohol psychiatry. The lecture explicitly identifies "6 causes of confusion in alcoholism" [1]:

#CauseKey Distinguishing FeaturesWhy This Happens
1Intoxication [1]History of recent alcohol intake; slurred speech, ataxia, nystagmus; BAC elevated; resolves as alcohol is metabolisedGABA-A potentiation + NMDA blockade → generalised CNS depression
2Delirium Tremens (DT) [1]Onset 48–72h after last drink; fluctuating consciousness, vivid visual hallucinations, tremor, autonomic storm (fever, tachycardia, sweating, hypertension)Abrupt loss of chronic GABA-A potentiation + unmasked NMDA hyperexcitability → excitotoxic state
3Head injury / Subdural haematoma [1]History of falls (common in alcoholics); focal neurological signs; may have lucid interval then deterioration; coagulopathy + thrombocytopenia increases bleeding riskAlcoholics fall frequently + have impaired clotting factors (hepatic dysfunction) + thrombocytopenia → bridging vein tears → subdural collection
4Metabolic disturbances (e.g. hypoglycaemia) [1]Confusion, aggression, sweating, tremor, seizures; H'stix confirms low glucose; responds to IV dextroseAlcohol metabolism consumes NAD⁺ → insufficient NAD⁺ for gluconeogenesis → hypoglycaemia. Often mimics intoxication exactly
5Hepatic encephalopathy [1]Asterixis (liver flap), fetor hepaticus, jaundice, stigmata of chronic liver disease; ↑ ammonia; often triggered by GI bleed, infection, constipationCirrhosis → failed hepatic clearance of ammonia → crosses BBB → astrocyte swelling (via glutamine accumulation) → cerebral oedema and altered neurotransmission
6Wernicke encephalopathy [1]Classic triad: confusion + ophthalmoplegia + ataxia (but only ~10% have full triad); responds to IV thiamineThiamine deficiency → impaired pyruvate dehydrogenase and α-ketoglutarate dehydrogenase → energy failure in metabolically active periventricular structures

The 6 Causes — Must Know for Exams

When you see a confused alcoholic patient, you MUST systematically consider all 6 causes. The commonest exam mistake is assuming the patient is "just drunk." Every confused alcoholic needs: H'stix (hypoglycaemia), thiamine (Wernicke), assessment for head injury (subdural), liver assessment (hepatic encephalopathy), and timeline from last drink (withdrawal/DT). Multiple causes can coexist — e.g. a patient can be both hypoglycaemic AND in withdrawal AND have a subdural.

Additional differentials for confusion in alcoholics (beyond the classic 6):

CauseDistinguishing Features
CNS infection (meningitis/encephalitis)Fever, neck stiffness, photophobia; immunocompromised state in alcoholics increases risk; LP needed
Drug overdose / polypharmacyUrine toxicology screen; check for co-ingestion of benzodiazepines, opioids, paracetamol
Electrolyte disturbance (beyond hypoglycaemia)HypoNa, hypoK, hypoMg, hypoPO₄ — all common in alcoholics due to poor intake, vomiting, and renal losses
Central pontine myelinolysisQuadriparesis, dysarthria, dysphagia; history of rapid Na⁺ correction
Alcoholic ketoacidosisAnion gap metabolic acidosis; occurs after binge followed by fasting; ketones elevated but glucose may be normal or low
Postictal stateHistory of witnessed seizure; gradual resolution; may occur after withdrawal seizure

When an alcoholic patient presents with hallucinations or delusions, you must distinguish between several entities [1][2]:

DiagnosisKey FeaturesHow to Differentiate
Alcoholic hallucinosis [1]Chronic heavy drinkers; auditory hallucinations; in clear consciousness; distressing in content; some develop schizophrenia, some remit after stopping alcohol use [1]Differentiate from delirium tremens: reduction in alcohol intake, clouded sensorium, visual hallucinations in DT [1]. Alcoholic hallucinosis has clear sensorium and predominantly auditory hallucinations
Delirium tremensVisual hallucinations (classically Lilliputian — small animals/insects), clouded/fluctuating consciousness, autonomic storm, tremorOnset 48–72h after cessation; clouded sensorium is the key distinguisher from hallucinosis
Alcohol-induced psychotic disorder (delusional)Typically morbid jealousy (Othello syndrome) — abnormal belief partner is unfaithful; incessant cross-questioning, searching for evidence; risk of violence [2]Content is specifically jealousy-themed; often in male chronic drinkers; other causes include schizophrenia, mood disorder, organic disorder, paranoid personality disorder [2]
Primary schizophreniaSchneiderian first-rank symptoms; persistent psychosis independent of alcohol use; deteriorating function over time; FHx of psychosisPsychotic symptoms persist > 4 weeks after abstinence; onset may predate alcohol use; negative symptoms prominent
Substance-induced psychosis (other substances)Stimulants (methamphetamine, cocaine) and cannabis are common causes; urine drug screen positiveTemporal relationship with substance use; resolves with clearance of substance
Mood disorder with psychotic featuresPsychosis is mood-congruent (e.g. nihilistic delusions in depression, grandiose delusions in mania); affective symptoms predominatePsychotic features occur within the context of a mood episode

Diagnosing a comorbid primary psychiatric disorder in an alcoholic is supported by [1]:

  • Evidence of psychiatric disorder before onset of alcohol abuse or dependence [1]
  • Evidence of persistent psychiatric symptoms during extended alcohol-free periods (over 4 weeks) [1]
  • First-degree biological relative has documented psychiatric disorder [1]

Alcohol-induced mood disorder [1]:

  • Moderate or heavy alcohol use [1]
  • Major depression or mania [1]
  • Persists for up to 4 weeks after abstinence [1]
  • Clears up on stopping alcohol [1]

The differential here asks: is the mood disorder primary (independent) or secondary (alcohol-induced)?

DiagnosisKey Distinguishing Features
Alcohol-induced depressive disorderTemporal relationship with heavy alcohol use; symptoms clear within 4 weeks of abstinence [1]; no history of depression before alcohol misuse
Primary major depressive disorder with comorbid alcoholismDepression predates alcohol use; persists > 4 weeks after sustained abstinence; FHx of mood disorder; response to treatment is much less likely if comorbid alcoholism is NOT dealt with [2]
Alcohol-induced mania [1]Manic symptoms in context of heavy alcohol use; resolves with abstinence
Bipolar I disorder with comorbid alcoholism60% of bipolar I patients have alcoholism [1]; manic/hypomanic episodes predate alcohol use or persist in abstinence; ↑ impulsivity during mania drives drinking
HypothyroidismFatigue, weight gain, cold intolerance, constipation; check TFT — alcoholics may have thyroid dysfunction
Adjustment disorderDepressive symptoms temporally related to a psychosocial stressor; does not meet full criteria for MDD; develops within 3 months of stressor [2]
Organic causes of depressionCushing syndrome, malignancy, cerebral pathology — clinical assessment and investigations guided by suspicion

The 4-Week Rule

If mood or anxiety symptoms persist for > 4 weeks after complete alcohol abstinence, the psychiatric disorder is more likely to be primary (independent) rather than alcohol-induced. This is a critical clinical and exam distinction. Alcohol-induced mood disorder should clear within 4 weeks; alcohol-induced anxiety may take up to 6 months.


Alcohol-induced anxiety disorder [1]:

  • Symptoms occur while patient is on heavy alcohol consumption [1]
  • Symptoms subside gradually on abstinence, but may persist up to 6 months [1]
  • Generalised anxiety disorders / Panic disorder / Phobic anxiety disorders / Social phobia / Obsessive compulsive disorder / PTSD can all be mimicked [1]
  • Must be distinguished from alcohol withdrawal syndrome [1]
DiagnosisKey Distinguishing Features
Alcohol withdrawalOnset within 6–48h of last drink; autonomic hyperactivity (tremor, sweating, tachycardia); time-limited; responds to BZDs
Alcohol-induced anxiety disorderOccurs during heavy consumption (not just on withdrawal); subside gradually with abstinence but may persist up to 6 months [1]
Primary anxiety disorder with self-medicationAnxiety predates alcohol use; persists in extended abstinence (> 6 months); FHx of anxiety; alcohol use may serve as self-medication in pre-existent anxiety disorders [2]
Medical causes of anxietyThyrotoxicosis, phaeochromocytoma (episodic), hypoglycaemia (episodic), PE, COPD, cardiac arrhythmia [2]
Medication/substance-induced anxietyStimulants (caffeine, amphetamines, cocaine); withdrawal from other sedatives (BZDs, opioids); medications (corticosteroids, sympathomimetics, anticholinergics) [2]

DiagnosisKey Distinguishing Features
Korsakoff syndromeProfound anterograde amnesia + confabulation; follows untreated Wernicke encephalopathy; mamillary body/medial thalamic damage; other cognitive functions relatively preserved
Alcoholic dementiaFrontal-predominant cognitive decline (executive dysfunction, personality change); multifactorial aetiology; diagnosed ≥ 8 weeks after abstinence [2]; cortical atrophy with enlarged ventricles on imaging
Alzheimer diseaseInsidious onset; progressive; hippocampal atrophy on MRI; amyloid/tau biomarkers; no clear relationship to alcohol intake
Vascular dementiaStepwise deterioration; vascular risk factors; white matter changes on MRI
Hepatic encephalopathyFluctuating; asterixis; ↑ ammonia; improves with lactulose/rifaximin
B12/folate deficiencyMegaloblastic anaemia (but can have neurological features without anaemia); subacute combined degeneration of cord; common in alcoholics due to malabsorption
Normal-pressure hydrocephalusClassic triad: gait apraxia, urinary incontinence, dementia; ventriculomegaly out of proportion to sulcal widening
Chronic subdural haematomaFluctuating consciousness, headache, focal signs; common in alcoholics (falls + coagulopathy)

DiagnosisKey Distinguishing Features
Alcohol withdrawal seizuresGeneralised tonic-clonic; onset 12–48h after last drink; often a single seizure or brief cluster; risk of kindling with repeated withdrawals
Primary epilepsyHistory of seizures unrelated to alcohol use; abnormal EEG; may require long-term AEDs
Hypoglycaemia-induced seizuresLow H'stix; responds to glucose
HyponatraemiaSerum Na⁺ < 120 mmol/L; check electrolytes urgently
Structural lesionSubdural haematoma, brain tumour, AVM; focal features on examination; CT/MRI needed
Meningitis/encephalitisFever, neck stiffness; LP findings
Hepatic encephalopathyAdvanced liver disease; ↑ ammonia

The relationship between alcoholism and psychiatric symptoms is bidirectional, with confounding factors [1]:

This means that when you encounter a patient with both alcohol misuse and psychiatric symptoms, you must consider three possibilities [1]:

  1. Alcohol → Psychiatric disorder (alcohol-induced): alcohol directly causes the psychiatric symptoms through neurotoxicity, neurotransmitter disruption, or nutritional deficiency
  2. Psychiatric disorder → Alcohol (self-medication): the patient drinks to cope with pre-existing psychiatric symptoms (e.g. social phobia → drinking to cope with social situations)
  3. Confounding factors: both the alcohol misuse and the psychiatric disorder are independently caused by shared risk factors (e.g. childhood trauma, genetics, social deprivation) [1]

The key clinical approach to untangling this [1]:

  • Evidence of psychiatric disorder BEFORE onset of alcohol abuse or dependence [1]
  • Persistent psychiatric symptoms during extended alcohol-free periods (over 4 weeks) [1]
  • First-degree biological relative has documented psychiatric disorder [1]

If these criteria are met, the psychiatric disorder is more likely primary (comorbid) rather than alcohol-induced.



Psychiatric comorbidity is very common in alcoholism (lifetime diagnosis occurs in 55% of alcoholics) [2]:

Comorbid ConditionPrevalenceKey Differentiating Point
Mood disorders40% of alcoholics [2]Depression is the most common comorbidity; 4× risk of MDD
Antisocial personality disorder80% of ASPD patients have alcoholism [1]Longstanding pattern of disregard for others' rights; onset before age 15
Bipolar I disorder60% of bipolar I patients [1]Manic episodes predate alcohol use; impulsivity drives drinking
Schizophrenia30% abuse alcohol [1]Alcohol decreases feeling of isolation; temporarily reduces anxiety/depression/insomnia; but increases psychotic symptoms and mood swings [1]
Drug addiction20% of drug abusers are alcoholic; alcoholics are 6× more prone to become drug abusers [1]Urine drug screen; polysubstance use history
Anxiety disordersSocial phobia, panic disorder common [1]May be self-medication; must distinguish from withdrawal

High Yield Summary

Differential Diagnosis of Alcohol-related Disorders — Key Exam Points:

  1. 6 causes of confusion in alcoholism (must memorise): Intoxication, DT, Head injury/subdural, Metabolic disturbances (hypoglycaemia), Hepatic encephalopathy, Wernicke encephalopathy
  2. Alcoholic hallucinosis vs DT: Hallucinosis = auditory hallucinations + clear sensorium; DT = visual hallucinations + clouded sensorium + autonomic storm
  3. Alcohol-induced vs primary psychiatric disorder: Use the 3 criteria — (i) psychiatric disorder before alcohol onset, (ii) persistent symptoms > 4 weeks of abstinence, (iii) FHx of psychiatric disorder
  4. Alcohol-induced mood disorder clears within 4 weeks of abstinence; alcohol-induced anxiety may persist up to 6 months
  5. The relationship is bidirectional with confounding factors — alcohol can cause, result from, or co-occur with psychiatric disorders
  6. Othello syndrome (morbid jealousy): a specific alcohol-related delusional disorder — beware risk of violence (56% of men)
  7. Always check: H'stix, BAC, NH₃, CT head, electrolytes, and timeline from last drink in any confused alcoholic

Active Recall - Differential Diagnosis of Alcohol-related Disorders

References

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p2, p7, p38, p40–p46, p48) [2] Senior notes: ryanho-psych.md (sections 5.1, 5.1.2; pages 96–110, 142–143, 155, 165)


A. Diagnostic Criteria

The diagnosis of alcohol-related disorders requires understanding three major classification systems that overlap but are not identical. Think of them as different lenses on the same problem: ICD-10 (used in HK clinical practice), DSM-5 (used in research and increasingly in clinical practice), and the historical Edwards & Gross criteria (which heavily influenced ICD-10 and remain conceptually important).

DSM-5 collapsed the older DSM-IV distinction between "alcohol abuse" and "alcohol dependence" into a single dimensional diagnosis: Alcohol Use Disorder (AUD), graded by severity. The logic: abuse and dependence exist on a continuum, not as discrete entities.

A problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: [1]

#CriterionDomainPathophysiological / Behavioural Basis
1Alcohol is often taken in larger amounts or over a longer period than was intended [1]Impaired controlPrefrontal cortex dysfunction → impaired executive decision-making; once drinking begins, mesolimbic DA surge overrides planned limits
2There is a persistent desire or unsuccessful efforts to cut down or control alcohol use [1]Impaired controlCraving driven by sensitised incentive-salience system; despite conscious intent to stop, compulsive circuit dominates
3A great deal of time is spent in activities necessary to obtain alcohol, use alcohol, or recover from its effects [1]Impaired controlAs dependence progresses, obtaining and using alcohol becomes the organising principle of the day
4Craving, or a strong desire or urge to use alcohol [1]Impaired controlConditioned cue-reactivity in amygdala/NAc; environmental triggers provoke DA surges → subjective craving
5Recurrent alcohol use resulting in a failure to fulfill major role obligations at work, school, or home [1]Social impairmentIntoxication, withdrawal, and preoccupation with alcohol directly interfere with functioning
6Continued alcohol use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of alcohol [1]Social impairmentImpaired insight + compulsive use overrides awareness of social consequences
7Important social, occupational, or recreational activities are given up or reduced because of alcohol use [1]Social impairmentReward hijacking — natural rewards pale compared to drug-induced DA; progressive narrowing of interests
8Recurrent alcohol use in situations in which it is physically hazardous [1]Risky useImpaired judgement (frontal lobe) + disinhibition → dangerous behaviour (e.g. drunk driving)
9Alcohol use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by alcohol [1]Risky useCompulsive circuit overrides rational assessment of harm
10Tolerance, as defined by either of the following: [1]Pharmacological
a. A need for markedly increased amounts of alcohol to achieve intoxication or desired effect [1]GABA-A receptor downregulation + NMDA receptor upregulation (pharmacodynamic tolerance); CYP2E1 induction (pharmacokinetic/metabolic tolerance)
b. A markedly diminished effect with continued use of the same amount of alcohol [1]Same neuroadaptive mechanisms — the brain "fights back" against chronic GABA potentiation
11Withdrawal, as manifested by either of the following: [1]Pharmacological
a. The characteristic withdrawal syndrome for alcohol [1]Unmasked NMDA hyperexcitability + loss of GABA-mediated inhibition
b. Alcohol (or a closely related substance, such as a benzodiazepine) is taken to relieve or avoid withdrawal symptoms [1]Negative reinforcement — drinking to abolish the aversive withdrawal state (relief drinking)

Severity grading:

  • Mild: 2–3 criteria
  • Moderate: 4–5 criteria
  • Severe: 6+ criteria

Specify remission: [2]

  • In early remission: none of criteria met for ≥ 3 months but < 12 months
  • In sustained remission: none met for ≥ 12 months
  • In a controlled environment: where access to alcohol is restricted

DSM-5 vs DSM-IV — Key Change

DSM-IV had two separate diagnoses: "Alcohol Abuse" (1 of 4 criteria) and "Alcohol Dependence" (3 of 7 criteria). DSM-5 merged them into one "Alcohol Use Disorder" with 11 criteria (need ≥ 2). The old "legal problems" criterion was dropped and "craving" was added. The logic: the abuse/dependence dichotomy was artificial — in practice, patients existed on a spectrum, and many who had "abuse" were already on the path to dependence.

ICD-10 retains the older two-tier system. This is important because HK clinical practice still uses ICD codes.

ICD-10 Harmful Use (F10.1): [2]

  • A pattern of substance use that is causing actual damage to physical or mental health
  • The damage may be physical (e.g. hepatitis) or mental (e.g. depression)
  • NOT diagnosed if: (1) acute intoxication or "hangover" alone; (2) dependence syndrome, psychotic disorder, or another specific alcohol-related disorder is present
  • Why this exclusion? Because harmful use is meant to capture the "intermediate" stage — if the patient already meets criteria for dependence, you code that instead (it's more severe and more specific)

ICD-10 Dependence Syndrome (F10.2): [2]

  • ≥ 3 of 6 criteria present together at some time during the previous year:
CriterionExplanation
(a) Strong desire or sense of compulsion to take the substanceCraving — the subjective experience of incentive-salience
(b) Difficulties in controlling substance-taking behaviour (onset, termination, levels of use)Loss of executive control over drinking
(c) Physiological withdrawal state when ceased/reduced, OR use of same/related substance to relieve/avoid withdrawalThe GABA-glutamate imbalance made manifest
(d) Evidence of toleranceNeuroadaptation — need more for same effect
(e) Progressive neglect of alternative pleasures or interests + increased time to obtain/use/recoverReward hijacking
(f) Persisting with use despite clear evidence of overtly harmful consequencesImpaired insight + compulsive loop

These are historically influential — they directly informed the ICD-10 dependence criteria. Think of them as the clinical description that preceded the formal criteria.

Edwards and Gross — Alcohol Dependence Syndrome: [2]

ElementDescriptionClinical Significance
1. Narrowing of repertoireDrinking becomes increasingly stereotyped — same type, same time, same placeThe dependent person's drinking pattern is rigid and predictable, unlike the flexible pattern of a social drinker
2. Increased salience of drinkingMaintaining the drinking pattern is given priority over other aspects of life (home, career, recreation)Functionally equivalent to DSM-5 criterion #7 (giving up activities)
3. Increased toleranceIncreased quantities needed; can tolerate BAC levels that would incapacitate non-tolerant drinkers. Note: tolerance can decrease in later stages of heavy drinkingEarly: neuroadaptive tolerance (GABA-A down, CYP2E1 up). Late: hepatic decompensation reduces metabolic capacity → apparent loss of tolerance
4. Withdrawal symptomsFall in BAC → tremor, nausea, vomiting, sweating, anxiety, depression, agitation. Heavier dependence → early morning withdrawal after a night's sleepWhy early morning? Because overnight abstinence (8+ hours) allows BAC to drop below the "set point" that the adapted brain now requires
5. Relief drinkingDrinking to relieve or avoid withdrawal symptoms (e.g. "eye-opener" — first drink of the day to stop morning tremor)Classic negative reinforcement; a very reliable indicator of physiological dependence
6. Subjective awareness of compulsionThe patient recognises a compulsive drive to drink and may resist but ultimately gives inDistinguishes dependence from simple heavy drinking — the element of loss of control
7. Reinstatement after abstinenceAfter a period of abstinence, relapse rapidly returns the patient to previous pattern of dependent drinkingThe neuroadaptive changes do not fully reverse — "memory" of dependence persists in the reward circuitry

Alcohol Intoxication DSM-5: [1]

CriterionDetail
ARecent ingestion of alcohol [1]
BClinically significant problematic behavioural or psychological changes (e.g. inappropriate sexual or aggressive behaviour, mood lability, impaired judgement) that developed during, or shortly after, alcohol ingestion [1]
COne or more of the following signs or symptoms developing during, or shortly after, alcohol use: [1]
1. Slurred speech — cerebellar and cortical motor depression
2. Incoordination — cerebellar Purkinje cell depression
3. Unsteady gait — cerebellar vermis + proprioceptive pathway depression
4. Nystagmus — vestibular nucleus and cerebellar flocculus depression
5. Impairment in attention or memory — NMDA blockade in hippocampus and prefrontal cortex
6. Stupor or coma — severe generalised CNS depression including brainstem
DThe signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance [1]

DSM-5 criteria for Alcohol Withdrawal:

  • A. Cessation of (or reduction in) alcohol use that has been heavy and prolonged
  • B. ≥ 2 of the following developing within hours to days after criterion A: (1) autonomic hyperactivity (sweating, tachycardia > 100 bpm); (2) increased hand tremor; (3) insomnia; (4) nausea or vomiting; (5) transient visual, tactile, or auditory hallucinations/illusions; (6) psychomotor agitation; (7) anxiety; (8) generalised tonic-clonic seizures
  • C. Symptoms cause clinically significant distress or impairment
  • D. Not attributable to another medical condition or mental disorder
  • Specify if: with perceptual disturbances (hallucinations with intact reality testing)

The following algorithm walks through the clinical approach to a patient with suspected alcohol-related problems, from initial suspicion through screening, comprehensive assessment, and definitive diagnosis.


C. Screening Tools — In Detail

The name is a mnemonic — each letter stands for one question:

LetterQuestionWhat It Detects
CHave you ever felt you should Cut down on your drinking?Awareness of excessive use
AHave people Annoyed you by criticising your drinking?Social impact
GHave you ever felt Guilty about your drinking?Emotional consequence
EHave you ever had a drink first thing in the morning (Eye-opener) to steady your nerves or get rid of a hangover?Relief drinking — highly suggestive of physiological dependence
  • Scoring: ≥ 2 "yes" answers = screen positive
  • ↑ Sensitivity but modest specificity only [2] — many false positives
  • Strength: very quick (4 questions, takes 30 seconds)
  • Weakness: does not quantify consumption; does not detect hazardous drinking below the dependence threshold; poor specificity in populations with high baseline drinking rates

↑ Sensitivity + ↑ Specificity, probably most useful. 10-item screening tool by WHO [2]

The AUDIT is the gold-standard screening tool. It covers three domains in 10 questions:

DomainQuestionsWhat It Measures
Consumption (Questions 1–3)Frequency of drinking, typical quantity, frequency of heavy drinkingQuantifies actual intake — detects hazardous drinking even without dependence
Dependence (Questions 4–6)Impaired control, failure to meet expectations, morning drinkingScreens for core dependence features
Alcohol-related harm (Questions 7–10)Guilt, blackouts, injury, concern from othersDetects consequences of drinking
  • Scoring: 0–40; ≥ 8 = hazardous drinking (screen positive)
  • Cut-offs for clinical action: 8–15 (brief intervention), 16–19 (extended intervention), ≥ 20 (further diagnostic evaluation for dependence)
  • Why AUDIT is superior to CAGE: it quantifies consumption (not just consequences), it has better specificity, it detects the full spectrum from hazardous use through to dependence

AUDIT vs CAGE — Exam Comparison

CAGE: 4 items, very quick, good sensitivity but modest specificity; detects dependence features but misses hazardous drinking. AUDIT: 10 items, takes 2–3 minutes, high sensitivity AND specificity; detects the full spectrum from hazardous use to dependence. For screening in clinical settings, AUDIT is preferred.

ScaleFull NamePurposeScoring
SADQSeverity of Alcohol Dependence Questionnaire [2]Estimates severity of dependence; predicts risk during detoxification> 30 is an indication for inpatient detoxification [2]
CIWA-ArClinical Institute Withdrawal Assessment Scale for Alcohol, revised [2]Quantifies severity of withdrawal (out of 67) [2]< 10 = very mild; 10–15 = mild; 16–20 = moderate; > 20 = severe [2]

CIWA-Ar assesses 10 domains: nausea/vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache/fullness, and orientation/clouding of sensorium. It is used to guide symptom-triggered benzodiazepine therapy (start at CIWA-Ar ≥ 8) [2].

Why symptom-triggered is preferred: it allows titration to the individual patient's actual withdrawal severity, avoids over-sedation in mild withdrawal, and has been shown to reduce total BZD dose and duration of treatment compared to fixed-dose schedules. However, it requires intensive monitoring (e.g. hourly assessments) [2].


A structured drinking history is the single most important diagnostic tool. It provides information that no blood test or screening questionnaire can:

ComponentWhat to AskWhy It Matters
Initiation [2]Reason for drinking, triggers, when did daily drinking startIdentifies the trajectory and potential psychological drivers
Use [2]Current, regular, maximal use; describe a typical day (especially note time of first drink) [2]Early morning drinking = relief drinking = strong indicator of dependence. A typical day reveals the pattern and total daily intake
Signs/symptoms of dependence [2]Compulsion/craving, difficulty in control, stereotyped behaviour, tolerance, withdrawal, persistent despite negative consequences, neglect of other activitiesDirectly maps to ICD-10/DSM-5 diagnostic criteria
Impact [2]Physical health, mental health, ADL, family, work, social relationshipsQuantifies functional impairment — essential for severity grading and treatment planning
Quitting [2]Dates and reasons of abstinence, dates and reasons of relapses, attitude toward changeAssesses stage of change (precontemplation → contemplation → preparation → action → maintenance); predicts treatment engagement

E. Investigation Modalities and Key Findings

Investigations serve four purposes in alcohol-related disorders:

  1. Confirm/quantify alcohol use (biomarkers)
  2. Assess severity of organ damage (blood tests, imaging)
  3. Detect and correct acute metabolic derangements (emergency labs)
  4. Rule out alternative diagnoses (CT, LP, toxicology)

InvestigationSensitivityKey PointsWhy This Marker Changes
↑ GGT (gamma-glutamyl transferase)70% [2]Useful screening tool but non-specific, dose-related [2]. Normalises within 2–6 weeks of abstinence. Also elevated in: hepatobiliary disease, obesity, medications (anticonvulsants, barbiturates), diabetes, pancreatitisAlcohol induces microsomal enzymes including GGT; also released from damaged hepatocytes
↑ MCV (mean corpuscular volume)60% [2]More commonly in females; strong indicator of excessive drinking once other causes ruled out; takes weeks to return to baseline after abstinence [2]Direct toxic effect of ethanol on erythroblast membranes (↑ membrane fluidity → ↑ cell size) + folate deficiency → impaired DNA synthesis → megaloblastic change. Takes weeks because MCV reflects average of circulating RBCs (lifespan ~120 days)
↑ CDT (carbohydrate-deficient transferrin)~70%More specific than GGT [2]. Best used for monitoring relapse after treatment. Normalises within 2–4 weeksChronic alcohol interferes with hepatic glycosylation of transferrin → ↑ proportion of under-glycosylated (carbohydrate-deficient) isoforms
Breath/blood alcohol concentration (BAC)N/AOnly reflects current drinking [2]. Useful in acute settings. No intoxication despite ↑↑ BAC can denote development of tolerance [2]Directly measures ethanol; metabolised at ~7–10 g/hour (zero-order kinetics)

Best combination for screening: GGT + MCV together have higher sensitivity than either alone. CDT is more specific and useful for relapse monitoring.

InvestigationKey Findings in AlcoholismInterpretation / Why
LFTsAST:ALT ratio > 2:1 (classic); ↑ GGT; ↑ bilirubin; ↓ albumin (if cirrhotic)AST > ALT because: (1) alcohol depletes hepatic pyridoxal-5′-phosphate (B6 cofactor for ALT more than AST); (2) mitochondrial AST (mAST) is released preferentially from alcohol-damaged mitochondria. The 2:1 ratio is fairly specific for alcoholic liver disease
FBC↑ MCV (macrocytosis ± megaloblastic anaemia); ↓ platelets (thrombocytopenia); ↓ WBC (leucopenia)Macrocytosis: direct toxicity + folate deficiency. Thrombocytopenia: direct marrow suppression + hypersplenism (portal hypertension → splenomegaly → sequestration). Leucopenia: direct marrow suppression
Coagulation↑ PT/INRLiver synthetic failure → ↓ production of clotting factors (especially II, VII, IX, X)
U&EHypoK⁺, hypoNa⁺, hypoMg²⁺, hypoPO₄³⁻HypoK: GI losses (vomiting, diarrhoea) + renal losses (↑ aldosterone from volume depletion). HypoNa: beer potomania (excess free water intake with low solute), SIADH, or dilutional. HypoMg: poor dietary intake + renal wasting + GI losses. HypoPO₄: refeeding shifts, poor intake
GlucoseHypoglycaemia (fasting or 6–36h post-ingestion)↑ NADH:NAD⁺ ratio → blocked gluconeogenesis
LipidsHypertriglyceridaemia↑ NADH drives ↑ fatty acid synthesis and ↓ fatty acid oxidation
Uric acid↑ UrateLactate (from ↑ NADH) competes with urate for renal tubular excretion
B12 / Folate↓ Folate (common), ↓ B12 (less common)Folate: poor dietary intake + malabsorption + alcohol directly impairs folate metabolism. B12: less commonly affected but can occur with chronic gastritis → ↓ intrinsic factor
Thiamine level↓ (often not routinely measured; treat empirically)Poor intake + impaired intestinal absorption + increased utilisation

  • Urine toxicology [2]: essential to rule out co-ingestion of other substances (benzodiazepines, opioids, stimulants, cannabis)
  • Why? 20% of drug abusers are alcoholic; alcoholics are 6× more prone to become drug abusers [1] — polypharmacy is common and can complicate withdrawal and management
  • Also important to check: paracetamol level (common co-ingestant in deliberate self-harm)

ModalityWhen to OrderKey Findings
CT head (non-contrast)Acute confusion to rule out subdural haematoma, subarachnoid haemorrhage; new seizures to rule out structural cause [2]Subdural haematoma (crescent-shaped hyper/hypo/mixed density); cortical atrophy with enlarged ventricles (chronic alcoholism); cerebellar vermis atrophy
MRI brainSuspected Wernicke encephalopathy; cognitive decline workup; suspected Marchiafava-BignamiWernicke: T2/FLAIR hyperintensity in mamillary bodies, medial thalami, periaqueductal grey, tectal plate. Alcohol-related dementia: cerebral cortical atrophy with enlarged lateral ventricles; loss of grey matter in cortical and subcortical areas; white matter changes with demyelination on DTI [2]. Cerebellar degeneration: cerebellar cortical atrophy especially affecting anterior vermis [2]. Marchiafava-Bignami: corpus callosum necrosis/demyelination. Central pontine myelinolysis: central pontine T2 hyperintensity [2]

InvestigationIndicationKey Findings
ECGBaseline; palpitations; pre-treatment (some medications prolong QT)AF (holiday heart); prolonged QT; signs of cardiomyopathy
Liver ultrasoundSuspected chronic liver diseaseSteatosis (bright liver), cirrhosis (coarse nodular echogenicity, ↓ liver size), portal hypertension (splenomegaly, ascites)
FibroScan (transient elastography)Staging of liver fibrosisNon-invasive estimation of liver stiffness; guides need for further hepatological follow-up
EEGSeizures of uncertain aetiology; suspected non-convulsive statusHelps distinguish withdrawal seizures from epilepsy; may show generalised slowing in encephalopathy
Nerve conduction studiesSuspected peripheral neuropathyAxonal sensorimotor polyneuropathy (reduced amplitudes, relatively preserved conduction velocities)
Ammonia levelSuspected hepatic encephalopathy↑ ammonia (though levels correlate poorly with clinical severity)
LPSuspected meningitis/encephalitisTo rule out CNS infection in a febrile, confused alcoholic patient (immunocompromised state)

Minimum workup in any acutely presenting patient:

CategoryTests
BedsideH'stix (glucose), vital signs (BP, HR, temp, O₂ sat), BAC (breathalyser), CIWA-Ar scoring
BloodsFBC (MCV, platelets), LFT (AST, ALT, GGT, ALP, bilirubin, albumin), RFT (Na, K, Cr, urea), glucose, Mg²⁺, PO₄³⁻, Ca²⁺, coagulation (PT/INR), B12/folate, thiamine (if available)
UrineUrine toxicology screen [2]
ImagingCT head if: new seizure, focal neurological signs, suspected head injury, altered consciousness not explained by intoxication/withdrawal
OtherECG, ammonia (if liver disease suspected), blood cultures (if febrile), CXR (aspiration pneumonia)

The AST:ALT > 2:1 Rule

In most liver diseases, ALT > AST. In alcoholic liver disease, the pattern reverses: AST:ALT > 2:1. Why? Alcohol depletes pyridoxal-5′-phosphate (vitamin B6), which is required more for ALT synthesis than AST. Additionally, mitochondrial AST (mAST) is released from alcohol-damaged hepatocyte mitochondria. This ratio is a useful clinical clue but not pathognomonic — it can also be seen in cirrhosis of any cause and in Wilson disease.


F. Diagnostic Criteria for Specific Alcohol-Induced Psychiatric Disorders

These are important because the lecture specifically highlights alcohol-related psychiatric disorders — alcohol-induced psychiatric disorders and comorbid conditions [1].

Diagnostic approach: [1]

  • Moderate or heavy alcohol use [1]
  • Major depression or mania [1]
  • Persists for up to 4 weeks after abstinence [1]
  • Clears up on stopping alcohol [1]

  • Symptoms occur while patient is on heavy alcohol consumption [1]
  • Symptoms subside gradually on abstinence, but may persist up to 6 months [1]
  • Generalised anxiety disorders / Panic disorder / Phobic anxiety disorders / Social phobia / Obsessive compulsive disorder / PTSD [1]
  • Must be distinguished from alcohol withdrawal syndrome [1]

  • Chronic heavy drinkers [1]
  • Auditory hallucinations [1]
  • In clear consciousness [1]
  • Distressing in content [1]
  • Some develop schizophrenia, some remit after stopping alcohol use [1]
  • Differentiate from delirium tremens — reduction in alcohol intake, clouded sensorium, visual hallucinations [1]

A comorbid primary psychiatric disorder (rather than alcohol-induced) is supported by: [1]

  • Evidence of psychiatric disorders before onset of alcohol abuse or dependence [1]
  • Evidence of persistent psychiatric symptoms during extended alcohol-free periods (over 4 weeks) [1]
  • First-degree biological relative has documented psychiatric disorder [1]

High Yield Summary

Diagnostic Criteria and Investigations — Key Exam Points:

  1. DSM-5 AUD: ≥ 2 of 11 criteria in 12 months. Mild (2–3), Moderate (4–5), Severe (6+). Single unified diagnosis replacing the old abuse/dependence dichotomy.
  2. ICD-10 Dependence: ≥ 3 of 6 criteria (compulsion, impaired control, withdrawal, tolerance, neglect, persistent use despite harm).
  3. Edwards & Gross: 7 elements — narrowing of repertoire, increased salience, tolerance, withdrawal, relief drinking, subjective compulsion, reinstatement after abstinence.
  4. DSM-5 Intoxication: Recent ingestion + behavioural change + ≥ 1 of 6 signs (slurred speech, incoordination, unsteady gait, nystagmus, attention/memory impairment, stupor/coma) + not better explained by another condition.
  5. Screening: AUDIT is best (10-item WHO tool, ↑ sens + spec, ≥ 8 screen positive). CAGE is quick but modest specificity.
  6. SADQ > 30 → inpatient detox. CIWA-Ar: < 10 very mild, 10–15 mild, 16–20 moderate, > 20 severe; guides symptom-triggered BZD therapy (start at ≥ 8).
  7. Lab biomarkers: ↑ GGT (70% sens, non-specific), ↑ MCV (60% sens, weeks to normalise), ↑ CDT (most specific). AST:ALT > 2:1 classic for alcoholic liver disease.
  8. Alcohol-induced vs comorbid psych disorder: Use 3 criteria — (i) psych disorder before alcohol, (ii) persistent symptoms > 4wk abstinence, (iii) FHx of psych disorder.
  9. Always get: H'stix, FBC, LFT, RFT, Mg, PO₄, coag, urine tox. CT head if confused/seizure/focal signs.

Active Recall - Diagnostic Criteria, Algorithm and Investigations

References

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p2, p4–5, p7, p19, p38, p42–43) [2] Senior notes: ryanho-psych.md (sections 5.1, 5.1.1, 5.1.2; pages 96–105, 108–110)

The management of alcohol-related disorders is staged — it depends entirely on where the patient sits at the time of presentation. A patient in acute intoxication needs different management from one in withdrawal, who in turn needs different management from one seeking long-term relapse prevention. The overarching framework is:

  1. Acute management — intoxication, withdrawal, DT, Wernicke encephalopathy
  2. Medium-term — detoxification (managed withdrawal)
  3. Long-term — relapse prevention (pharmacological + psychosocial)

Let's build this systematically.



B. Acute Management

The management is primarily supportive [2]. Why? Because ethanol is metabolised at a fixed rate (~7–10 g/hour, zero-order kinetics) — there is no antidote that speeds this up. Your job is to keep the patient alive and safe while the alcohol clears.

StepActionRationale
ABCAirway protection (recovery position; intubation if GCS ≤ 8 or aspiration risk), breathing, circulationSevere intoxication → respiratory depression (medullary depression); aspiration pneumonia from vomiting
IV fluid hydration [2]Correct volume depletion and hypotension [2]Alcohol causes osmotic diuresis + suppression of ADH → dehydration; vomiting further depletes volume
H'stixCheck capillary blood glucoseHypoglycaemia is an important differential in confused patient with prior alcohol intake [2] — mimics intoxication exactly
D50 infusion [2]If hypoglycaemia is present [2]Corrects energy substrate deficit; prevents brain injury
100 mg parenteral thiamine [2]Mandatory if present with coma (for prevention of B₁ deficiency) [2]Chronic alcoholics are universally at risk of thiamine depletion — glucose loading without thiamine can theoretically precipitate or worsen Wernicke encephalopathy
Thiamine + dextrose timing [2]Traditional teaching: thiamine before dextrose. Evidence: weak, likely NOT evidence-based → thiamine can be given together with dextrose [2]The theoretical basis is that glucose loading in a thiamine-deficient cell diverts remaining thiamine to glycolysis, starving thiamine-dependent TCA cycle enzymes → lactic acidosis. In practice, the urgency of treating hypoglycaemia outweighs this theoretical risk — give both simultaneously
BZD or FGA if agitated [2]Short-acting BZD (e.g. lorazepam) or haloperidolAgitated/combative intoxicated patients pose risk to themselves and staff; BZDs are preferred because they share the GABA mechanism; FGAs may be needed if psychotic features present but use cautiously (lower seizure threshold)
MonitoringRegular vitals, GCS, H'stix, temperatureWatch for deterioration — could indicate developing subdural, worsening intoxication (continued absorption), or early withdrawal if blood alcohol level begins to fall

The 3 Things You Must Do for Every Confused Alcoholic

  1. Check H'stix — hypoglycaemia kills and is trivially treatable
  2. Give thiamine — Wernicke encephalopathy is preventable but irreversible if missed
  3. CT head if any doubt — subdural haematoma is common in alcoholics who fall

Never assume "just drunk" until you have excluded these three emergencies.

2. Management of Alcohol Withdrawal [1][2]

Alcohol withdrawal syndrome [1]:

  • Occurs 6–24 hours after last drink [1]
  • Autonomic hyperactivity — tremulousness, sweating, nausea, vomiting, anxiety, agitation, tachycardia [1]
  • Hypertension, hyperreflexia, insomnia, nightmares, sweating, hyperthermia [1]
  • Down-regulation of GABA receptor in chronic alcoholics [1]
  • Reversal of inhibition of NMDA receptor → glutamate overactivity [1]
  • Disappears in 2–7 days [1]

The treatment principle follows directly from the pathophysiology: the brain is in a state of GABA deficiency and NMDA excess. The treatment is to restore GABAergic tone using a cross-tolerant GABA-A agonist (benzodiazepine) while the brain gradually readapts.

  • Hx, P/E: alcohol use and its complications [2]
  • Ix: CBC, L/RFT, glucose, urine toxicology [2]
  • CT brain: useful to rule out alternative diagnosis in seizures [2]
  • SADQ: estimates severity of dependence and thus predicts risk in detoxification [2]
    • > 30 is an indication for inpatient detoxification [2]
  • CIWA-Ar scale: quantifies severity of withdrawal (out of 67) [2]
    • Interpretation: < 10 = very mild, 10–15 = mild, 16–20 = moderate, > 20 = severe [2]

Indications for inpatient detoxification include: [2]

IndicationRationale
Severe dependence, e.g. SADQ > 30 [2]Higher risk of severe withdrawal including seizures and DT
History of severe withdrawal symptoms, e.g. seizures, DT [2]Kindling effect — each successive withdrawal is more severe; prior DT is the strongest predictor of future DT
Very high alcohol consumption (> 30 units/day) [2]Greater degree of neuroadaptation → more severe rebound excitotoxicity
Concomitant BZD misuse (↑↑ withdrawal severity) [2]Both alcohol and BZDs act on GABA-A; dual withdrawal is synergistic and potentially lethal
Significant medical/psychiatric comorbidity [2]Comorbid illness increases complications; psychiatric comorbidity increases suicide risk during withdrawal
ComponentDetailsMechanism / Rationale
Rule out alternative diagnoses [2]CNS infection, drug overdose, metabolic derangement, liver failure [2]All can mimic withdrawal; treating withdrawal alone when the real problem is meningitis or subdural is dangerous
Supportive care [2]NPO (if vomiting), correct volume deficits, stabilise haemodynamics [2]Dehydration from sweating, vomiting, poor intake; electrolyte loss
Correct metabolic derangements [2]Hypoglycaemia, hypoK, hypoMg, hypoPO₄, ketoacidosis [2]All common in alcoholics and all worsen withdrawal. HypoMg is particularly important — it lowers the seizure threshold AND impairs thiamine utilisation
Thiamine + glucose [2]To prevent Wernicke encephalopathy [2]Prophylactic thiamine for ALL patients in withdrawal — the cost of a missed Wernicke is devastating
Multivitamins with folate [2]For nutritional supplements [2]Chronic alcoholics are universally malnourished; folate deficiency → megaloblastic change
Benzodiazepines [1][2]↓ Agitation and ↓ withdrawal [2]Cross-tolerance with alcohol at GABA-A receptor — BZDs substitute for the lost GABAergic effect of alcohol, allowing a controlled taper

Choice of agent:

AgentPropertiesWhen to Use
Chlordiazepoxide (Librium) [2]Long-acting; smoother withdrawal; less abuse potentialFirst-line for planned detox [2]; oral dosing; gradual taper over 5–10 days
Diazepam (Valium) [2]Long-acting (T½ ~20–100h including active metabolites); rapid onsetAlternative first-line [2]; good for acute control; metabolised to active metabolites (desmethyldiazepam) → smooth self-tapering effect
Oxazepam [2]Short-acting; NO active metabolites; does NOT undergo hepatic oxidation (only glucuronidation)Preferred if severe liver disease present [2] — because cirrhotic liver cannot handle phase I metabolism (oxidation) of other BZDs; also safe in elderly
LorazepamShort-acting; no active metabolites; glucuronidation onlyAlternative in liver disease; also available IV for acute DT/seizures

Dosing approach:

StrategyDescriptionProsCons
Symptom-triggered [2]CIWA-Ar ≥ 8 triggers BZD dose; reassess at least hourly [2]Tailored to individual need; ↓ total BZD dose; ↓ duration of treatment; ↓ over-sedationRequires intensive monitoring (e.g. Q1h) [2] — not feasible in all settings
Fixed-schedulePredetermined doses at set intervals (e.g. chlordiazepoxide 30 mg QID reducing by 5 mg/day)Does not require hourly monitoring; simplerRisk of over-sedation in mild withdrawal; risk of under-treatment in severe withdrawal
Prophylactic [2]Oral chlordiazepoxide (Librium); oxazepam if severe liver disease [2]Prevents progression to severe withdrawalIndication: ↑ risk of severe withdrawal (e.g. Hx of seizures/DT) but currently admitted for other reasons with minimal withdrawal symptoms [2]

Why Long-Acting BZDs?

Long-acting BZDs (diazepam, chlordiazepoxide) are preferred because their active metabolites provide a smooth, self-tapering effect — the drug gradually wears off as the brain readapts. Short-acting BZDs (lorazepam, oxazepam) require more frequent dosing but are safer in liver disease because they bypass hepatic oxidation. Think of it like this: long-acting BZDs ride the wave down gently; short-acting ones create multiple small waves that need to be carefully managed.

Delirium tremens is a medical emergency requiring hospitalisation [1]:

  • Severe form of alcohol withdrawal [1]
  • Occurs in about 24–96 hours of abstention [1]
  • Confusion, hallucination, severe agitation, seizure [1]
  • Mortality 5% [1]

Management of DT [1]:

InterventionDetailsRationale
Benzodiazepines in decreasing dosage [1]Lorazepam / diazepam / others [1]. Often requires high doses — IV diazepam 10–20 mg every 5–15 min until calm (no fixed upper limit in DT; titrate to clinical effect)Restores GABA-A tone; controls agitation, autonomic storm, and prevents seizures
Anticonvulsants [1]Carbamazepine [1]Adjunct for seizure prevention; acts via sodium channel blockade and may also modulate glutamate. Not a substitute for BZDs in DT but can be useful as adjunct or prophylaxis
Proactive use of parenteral vitamins (thiamine) [1]IV thiamine 500 mg TDS for 3 days (Pabrinex or equivalent)Prevents Wernicke encephalopathy — DT patients are at extreme risk
Neuroleptics for control of agitation [1]Haloperidol (low dose, e.g. 2–5 mg); avoid in isolation — always give with BZDsControls psychotic symptoms (hallucinations, paranoid delusions) and severe agitation. BUT: antipsychotics lower seizure threshold → never use alone without BZD cover
Fluid and electrolyte balance [1]IV fluids (0.9% NaCl or balanced crystalloid); replace K⁺, Mg²⁺, PO₄³⁻Profound losses from sweating, fever, agitation; hypoMg lowers seizure threshold
Barbiturates or propofol [2]For refractory DT [2] — when BZDs fail to control symptoms despite high dosesBarbiturates (phenobarbital) act at a different site on GABA-A (prolong channel opening vs BZD which increase frequency); propofol for ICU-level sedation

Refractory DT — What Counts as Failure?

If a patient requires > 50 mg diazepam in the first hour or continues to have severe agitation/autonomic instability despite adequate BZD dosing, consider refractory DT. Escalate to phenobarbital (200 mg IV boluses) or propofol infusion (requires intubation and ICU). These cases have a mortality approaching 15% and need ICU management.

  • Most alcohol withdrawal seizures are self-limiting (< 5 minutes, generalised tonic-clonic)
  • Immediate treatment: IV lorazepam 4 mg (or IV diazepam 10 mg)
  • Status epilepticus: BZDs, phenobarbital, propofol [2]
  • Long-term anticonvulsants are generally NOT indicated for isolated withdrawal seizures — the seizures are provoked by withdrawal, not by an underlying epileptic disorder
  • Always CT head to rule out structural cause (subdural, SAH) — especially if focal features, first seizure, or atypical presentation

Wernicke's encephalopathy [1]:

  • Medical emergency [1]
  • 20% mortality [1]
  • Only 20% detected in life [1] — highlighting the need for high clinical suspicion and low threshold for treatment
  • IM/IV Thiamine [1]
  • Progression to Korsakoff's Psychosis in 84% [1] if untreated
TreatmentDetailsRationale
IV thiamine500 mg TDS for 3 days, then 250 mg daily for 3–5 daysThiamine pyrophosphate (TPP) is essential cofactor for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase. High-dose IV ensures adequate CNS penetration (only ~5% of oral thiamine is absorbed; in alcoholics, absorption is even lower due to damaged GI mucosa)
Then oral thiamine100 mg TDS ongoingMaintenance supplementation after acute phase
Why NOT oral alone?Oral bioavailability of thiamine is extremely poor in alcoholicsChronic alcohol damages jejunal mucosa (where thiamine is actively absorbed via THTR-1 transporter) AND alcohol directly inhibits thiamine transporter expression

Approach to management of alcohol misuse (NICE 2014): [2]

SeverityManagement
At-risk / hazardous drinking (non-dependent)Brief intervention [2] — simple education and advice about safe levels of alcohol consumption
Mild dependence [2]Offer a high-intensity psychotherapy [2]
Moderate / severe dependence [2]Offer acamprosate / PO naltrexone in combination with a high-intensity psychological treatment [2]
↑ Intake (> 15 units/day) and/or ≥ 15–30 on SADQ [2]Offer acute treatment vs withdrawal in community or inpatient settings (depending on safety) [2]

Goal of treatment [2]:

  • Controlled drinking for those detected early, non-dependent with minimal health sequelae [2]
  • Total abstinence for those who were dependent, with failed prior attempts at controlled drinking [2]

D. Long-term Pharmacological Treatment — Relapse Prevention

These medications are used after detoxification to help maintain abstinence or reduce heavy drinking. They work through different mechanisms and have different indications.

PropertyDetail
Drug classNMDA receptor modulator / glutamate antagonist
Name breakdown"a-camprosate" — derived from calcium acetyl-homotaurinate; structurally similar to GABA and glutamate
Mechanism of actionRestores the balance between glutamatergic excitation and GABAergic inhibition that is disrupted by chronic alcohol use. Specifically: (1) antagonises mGluR5 receptors → ↓ glutamatergic hyperexcitability; (2) may weakly potentiate GABA-A. Reduces the "hyperexcitable" brain state that drives craving and relapse
IndicationModerate/severe dependence, in combination with high-intensity psychological treatment [2]. First-line for relapse prevention (NICE)
ContraindicationsSevere renal impairment (renally excreted — not hepatically metabolised, so actually safe in liver disease); pregnancy/breastfeeding
TimingStart as soon as abstinence is achieved (during or immediately after detox); continue for 6–12 months
Key advantageSafe in liver disease (unlike disulfiram, which requires hepatic metabolism and monitoring)
EfficacyNNT ~12 to prevent one return to any drinking over 3–12 months

Why Acamprosate Works — From First Principles

Remember: chronic alcohol causes NMDA receptor upregulation. After alcohol is removed, these upregulated NMDA receptors are no longer suppressed → excessive glutamatergic excitation → this is what drives the persistent dysphoria, anxiety, craving, and "protracted withdrawal" that makes relapse so common in the weeks-months after detox. Acamprosate dampens this glutamatergic hyperexcitability, essentially easing the brain's transition back to a non-alcohol-adapted state.

PropertyDetail
Drug classOpioid receptor antagonist
Name breakdown"nal-" = nalorphine derivative (opioid antagonist prefix); "-trexone" = long-acting modification
Mechanism of actionBlocks µ-opioid receptors in the mesolimbic reward pathway. Alcohol normally stimulates endogenous opioid (β-endorphin) release → DA release in NAc → pleasurable reinforcement. Naltrexone blocks this pathway → ↓ reinforcing "buzz" from drinking → ↓ craving → if the patient does drink, the rewarding effect is blunted
IndicationModerate/severe dependence, in combination with high-intensity psychological treatment [2]. Can be used even if the patient is still drinking (harm reduction approach)
ContraindicationsConcurrent opioid use (will precipitate acute opioid withdrawal); severe hepatic impairment (hepatotoxicity risk at high doses); acute hepatitis
Side effectsNausea (commonest), headache, dizziness, fatigue, hepatotoxicity at high doses
Dosing50 mg PO daily; injectable extended-release (380 mg IM monthly — Vivitrol) available in some settings
Key advantageReduces heavy drinking days even if full abstinence is not achieved → useful for harm reduction

PropertyDetail
Drug classAldehyde dehydrogenase (ALDH) inhibitor
Name breakdown"di-sulfiram" = contains two sulfur groups; originally discovered as a rubber vulcanisation agent whose workers developed unpleasant reactions to alcohol
Mechanism of actionIrreversibly inhibits ALDH → if patient drinks alcohol, acetaldehyde accumulates → extremely unpleasant "disulfiram-ethanol reaction" (DER): flushing, nausea, vomiting, headache, tachycardia, hypotension, chest pain. This creates a powerful negative reinforcement — the patient learns to associate drinking with severe aversive consequences
IndicationPatients who are highly motivated and want a "safety net" to reinforce abstinence; supervised consumption (e.g. by spouse, nurse, or pharmacy) is most effective
ContraindicationsCardiac disease (DER can cause arrhythmia, MI); severe hepatic impairment; pregnancy; psychosis (can worsen); patients who are unreliable or impulsive (risk of deliberate drinking on disulfiram → medical emergency)
Side effectsWithout alcohol: drowsiness, fatigue, garlic-like taste. With alcohol: the DER (see above) — can be life-threatening in severe cases (cardiovascular collapse)
Key advantageVery effective when supervised; particularly useful in patients who have achieved abstinence and want to prevent impulsive relapse
Key disadvantageRequires absolute motivation and compliance; unsupervised use has poor outcomes; hepatotoxicity requires LFT monitoring

Disulfiram = Pharmacological ALDH2*2

Disulfiram pharmacologically mimics what the ALDH2*2 mutation does genetically in East Asians. Both cause acetaldehyde accumulation → aversive reaction → deterrence from drinking. The principle is identical — aversion therapy through biochemical consequences.

PropertyDetail
Drug classOpioid receptor antagonist (partial agonist at κ-receptors)
Name breakdown"nal-" = opioid antagonist prefix; "-mefene" = methylenated derivative
Mechanism of actionSimilar to naltrexone (µ-opioid antagonist) but with additional partial agonism at κ-opioid receptors → may provide additional anti-reward effects
IndicationOpioid antagonist, superior to placebo in severe dependence only [2]. Licensed for reduction of alcohol consumption (as-needed dosing before anticipated drinking occasions) rather than for maintaining abstinence
ContraindicationsConcurrent opioid use; severe hepatic/renal impairment
Key difference from naltrexoneTaken "as needed" (PRN) rather than daily; specifically for harm reduction in patients not yet ready for abstinence

  • May be useful in those with comorbid depression [2]
  • SSRIs are first-line if treating comorbid depression
  • NOT effective for alcohol dependence in the absence of comorbid depression
  • Important: response to treatment of mood disorder is much less likely if comorbid alcoholism is NOT dealt with [2] — always treat the alcohol problem alongside the depression

FeatureAcamprosateNaltrexoneDisulfiramNalmefene
Mechanism↓ Glutamatergic hyperexcitabilityBlocks opioid-mediated rewardALDH inhibition → aversive reactionµ-opioid antagonist + κ partial agonist
GoalMaintain abstinence↓ Heavy drinking / maintain abstinenceEnforce abstinence↓ Heavy drinking
TimingStart at abstinence; dailyDaily or IM monthlyDaily (supervised)PRN before drinking
Liver safetySafe (renally excreted)Caution (hepatotoxic at high dose)Caution (hepatotoxic; needs LFT monitoring)Caution
Use with opioids?YesNO (precipitates withdrawal)YesNO
NICE first-line?Yes (with naltrexone)Yes (with acamprosate)Second-lineFor harm reduction

E. Psychosocial Treatment [2]

Psychosocial interventions are the backbone of long-term management. Medications improve outcomes, but without addressing the psychological and social drivers of drinking, relapse is nearly inevitable.

  • Efficacious for non-dependent, at-risk alcohol use [2]
  • Involves: simple education and advice about safe levels of alcohol consumption [2]
  • Efficacy: usually modest reduction in alcohol consumption over next few years [2]
  • Utility: best for those with at-risk drinking (alcohol use above limit but non-dependent) [2]
  • Typical format: 5–15 minute structured conversation (FRAMES: Feedback, Responsibility, Advice, Menu of options, Empathy, Self-efficacy)

  • Basis: transtheoretical model of behaviour change — asserts that there are different levels of readiness to change among individuals [2]
    • Stages: precontemplation → contemplation → preparation → action → maintenance → (relapse is part of the cycle)
  • MI assesses readiness for change followed by attempts to build internal motivation to change based on patient's stage [2]
  • Principles: express empathy, develop discrepancy, roll with resistance, support self-efficacy [2]
  • Techniques [2]:
    • Engage patient thoughtfully by reflective listening
    • Focusing on a specific issue to be changed
    • Evoking patient's own thoughts that motivate them towards change
    • Planning, at least in the conceptual aspect, for changes
  • Efficacy: effective at short- and long-term across all substances [2]
  • Utility: allows patient to generate own arguments and motivation for change; facilitates change especially when patient is ambivalent [2]

MI — The 'Spirit' of the Approach

MI is NOT about telling the patient what to do. It is about helping the patient discover their own reasons for change. The core insight is that humans resist being told what to do (reactance), but are more likely to change when they articulate their own reasons. The clinician's role is to create the conditions where this self-discovery can happen — through empathic, non-judgemental, curious questioning.

  • Structured goal-directed form of psychotherapy [2]
  • Involves [2]:
    • Psychoeducation to let patient understand how their thought processes contribute to their behaviour
    • Behavioural treatment to help patients develop new and adaptive ways of behaving and alter their social environment → in turn leads to change in thoughts and emotions
  • Efficacy: modest positive effects on substance use [2]
  • Specific CBT techniques for alcohol include: identifying high-risk situations, developing coping strategies, cognitive restructuring of pro-drinking beliefs, relapse prevention training

  • Alcoholics Anonymous (AA) [2]: 12-step programme; peer support; emphasis on powerlessness over alcohol, spiritual growth, and lifelong commitment to abstinence
  • Efficacy: strong evidence for AA/12-step facilitation; comparable to CBT in maintaining abstinence
  • Not suitable for all (some patients find the spiritual emphasis off-putting; alternatives include SMART Recovery)

  • Cue exposure therapy: to ↓ effect of drinking cues and to prevent relapse [2] — based on classical conditioning principles; repeated exposure to alcohol-related cues without drinking leads to extinction of the conditioned craving response
  • Contingency management: offer incentives to encourage abstinence or discourage substance use [2] — operant conditioning; positive reinforcement for drug-free urine samples or attendance at sessions

ConditionManagementKey Points
Alcohol-induced mood disorder [1]Abstinence — clears up on stopping alcohol; persists for up to 4 weeks after abstinence [1]If depression persists > 4 weeks after abstinence → consider primary mood disorder → treat with antidepressant
Alcohol-induced anxiety disorder [1]Abstinence — symptoms subside gradually but may persist up to 6 months [1]Must be distinguished from alcohol withdrawal syndrome [1]; if persists > 6 months → primary anxiety disorder
Alcoholic hallucinosis [1]Treatment with antipsychotics and advice to abstain from alcohol [1]Some develop schizophrenia, some remit after stopping alcohol use [1]
Morbid jealousy (Othello syndrome) [2]Antipsychotics + abstinence [2]Beware risk of violence (56% of men) [2]; may need couple safety planning
Alcohol-related sleep disorders [2]Abstinence; sleep hygiene; sleep changes persist for 2 years after abstinence [2]Avoid using BZDs for sleep in recovering alcoholics (cross-dependence risk)

When schizophrenia is comorbid with alcoholism (30%) [1]:

  • Alcohol decreases feeling of isolation [1]
  • Temporarily reduces symptoms of anxiety / depression / insomnia [1]
  • BUT increases psychotic symptoms and mood swings [1]
  • Disruptive behaviour, suicide, treatment non-compliance, drug abuse, poor clinical outcome [1]
  • Drug accumulation due to hepatic damage [1]
  • Management: treat both simultaneously; optimise antipsychotic medication; be aware that hepatic damage alters drug metabolism → risk of toxicity at standard doses

Key principle: response to treatment is much less likely if comorbid alcoholism is NOT dealt with in a patient with a mood disorder [2]. Always address alcohol dependence as part of the treatment plan for any comorbid psychiatric condition.


High Yield Summary

Management of Alcohol-related Disorders — Key Exam Points:

  1. Acute intoxication: Supportive — ABC, IV fluids, H'stix, thiamine (before or with glucose), BZD/FGA if agitated. No antidote.
  2. Withdrawal: BZDs are cornerstone — prefer long-acting (chlordiazepoxide, diazepam); use oxazepam/lorazepam in liver disease. Symptom-triggered dosing (CIWA-Ar ≥ 8) preferred over fixed-schedule.
  3. DT: Medical emergency (5% mortality). IV BZD in decreasing dosage, anticonvulsants (carbamazepine), parenteral thiamine, neuroleptics for agitation, fluid/electrolyte balance. Barbiturates/propofol for refractory cases.
  4. Wernicke: Medical emergency (20% mortality). IV thiamine 500 mg TDS × 3 days. Only 20% detected in life → low threshold for treatment. 84% progress to Korsakoff if untreated.
  5. Inpatient detox indications: SADQ > 30, Hx seizures/DT, > 30 units/day, concurrent BZD misuse, significant comorbidity.
  6. NICE staged approach: At-risk → brief intervention. Mild dependence → psychotherapy. Moderate/severe → acamprosate or naltrexone + psychotherapy.
  7. Relapse prevention drugs: Acamprosate (↓ glutamate, safe in liver disease), Naltrexone (blocks opioid reward, CI in opioid use), Disulfiram (ALDH inhibitor → aversive reaction, needs supervision), Nalmefene (PRN harm reduction).
  8. Psychosocial: MI (assess readiness, build motivation), CBT (identify triggers, develop coping), AA (12-step peer support), Brief intervention (at-risk drinkers).
  9. Treatment goals: Controlled drinking (early, non-dependent) vs Total abstinence (dependent, failed controlled drinking).
  10. Always treat alcohol alongside comorbid psychiatric disorders — response to psych treatment is much less likely if alcoholism is not addressed.

Active Recall - Management of Alcohol Misuse and Alcohol-related Disorders

References

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p10, p12, p14, p38, p40–41, p44) [2] Senior notes: ryanho-psych.md (sections 5.1, 5.1.1, 5.1.2; pages 96–105, 109–110; section 3.1.4.1 on BZDs; section 3.3.4 on psychotherapy indications)

Alcohol is arguably the most damaging substance to the human body when used chronically — it affects virtually every organ system. The complications are best understood through the lens of four overarching mechanisms of damage:

  1. Direct cytotoxicity — ethanol and its metabolite acetaldehyde are directly toxic to cell membranes, mitochondria, and DNA
  2. Nutritional deficiency — chronic alcoholics eat poorly, absorb nutrients poorly (damaged GI mucosa), and alcohol directly interferes with vitamin metabolism (especially B1, B3, B6, B12, folate)
  3. Metabolic disruption — the massive shift in hepatic NAD⁺/NADH ratio disrupts gluconeogenesis, fatty acid oxidation, the TCA cycle, and uric acid excretion
  4. Immune dysregulation — chronic alcohol suppresses both innate and adaptive immunity → increased susceptibility to infections

Every complication below can be traced back to one or more of these four mechanisms. Let's work through each system.


A. Acute Complications

  • Dose-dependent CNS depression (covered in detail in prior sections)
  • Alcoholic blackouts: transient amnesia lasting hours, without impairment of conscious level; caused by NMDA receptor inhibition in hippocampus → failure of long-term potentiation (LTP) [2]
  • Traumatic brain injury: falls during intoxication are extremely common; alcoholics have impaired balance (cerebellar), poor judgement (prefrontal), and impaired protective reflexes → head injuries → subdural haematoma (further compounded by coagulopathy and thrombocytopenia)

  • Occurs 6–36h after ingestion of > 30g alcohol [2]
  • Mechanism: alcohol metabolism consumes NAD⁺ → ↑↑ NADH:NAD⁺ ratio → insufficient NAD⁺ for gluconeogenesis → hypoglycaemia [2]
  • Mimics intoxication exactly (confusion, aggression, stupor, hypothermia) → always check H'stix [2]

  • Occurs after a binge followed by fasting/vomiting → depleted glycogen stores + ↑ NADH:NAD⁺ ratio + ↑ free fatty acid mobilisation → ↑ ketone body production (β-hydroxybutyrate predominates over acetoacetate because of the shifted redox state)
  • Presents with: anion-gap metabolic acidosis, abdominal pain, nausea, vomiting, tachypnoea (Kussmaul breathing)
  • Glucose may be low, normal, or mildly elevated (unlike diabetic ketoacidosis where glucose is markedly elevated)
  • Mx: IV fluids (NS with dextrose), thiamine, electrolyte correction

ComplicationTimelineKey FeaturesMortality
Withdrawal syndrome6–24h after last drinkTremor, sweating, nausea, anxiety, tachycardia, hypertension [1]Low if treated
Withdrawal seizures12–48hGeneralised tonic-clonic; risk of kindling [2]Low if single; status epilepticus can be fatal
Delirium tremens [1]24–96 hours of abstention [1]Confusion, hallucination, severe agitation, seizure [1]. Autonomic stormMortality 5% [1]; < 5% if treated, up to 35% untreated

B. Chronic Neurological Complications

Alcoholism affects the brain front (frontal dementia), back (cerebellar vermis) and centre (corpus callosum) [2] — this mnemonic elegantly captures the three major chronic brain lesions.

This is the single most important neurological complication to understand.

Wernicke Encephalopathy (WE) [1][2]:

  • Mostly alcoholic / some non-alcoholic [1]
  • Thiamine deficiency [1]
  • Only 20% detected in life (Harper 1983) [1] — the classic triad is only present in ~10–16% of cases; most are diagnosed post-mortem
  • Medical emergency [1]
  • 20% mortality [1]
  • IM/IV Thiamine [1]
  • Progression to Korsakoff's Psychosis in 84% (Victor 1989) [1]
  • Clinical triad [2]:
    • Encephalopathy: delirium with profound disorientation, apathy, inattention, amnesia [2]
    • Oculomotor dysfunction: ophthalmoplegia (combination of bilateral palsies), nystagmus (most commonly horizontal but can be vertical), pupillary abnormalities (sluggish or unequal pupils) [2]
    • Truncal ataxia: vermis-type — ataxic, wide-based gait with short steps [2]
    • Other features: polyneuropathy (50%), hypothermia (1–4%), vestibular dysfunction, coma (rare) [2]
  • Diagnosis [2]: Caine criteria (≥ 2 out of 4): dietary deficiency, oculomotor abnormalities, cerebellar dysfunction, altered mental state or amnesia [2]
  • Imaging: T2/FLAIR hyperintensity in mammillary bodies, medial thalami, periaqueductal grey [2]
  • Course with treatment: ocular signs improve within hours to days; confusion subsides in days to weeks [2]
  • Prognosis: mortality 17% in acute stage; majority have residual deficits (nystagmus, ataxic gait, memory deficits) [2]

Korsakoff Syndrome [2]:

  • Develops in 84% of untreated WE patients [1]
  • Profound anterograde amnesia (inability to form new memories) with relative preservation of other cognitive functions
  • Confabulation — fabricated memories to fill gaps (the brain's attempt to make narrative sense of missing data; not deliberate lying)
  • Retrograde amnesia with temporal gradient (more recent memories lost preferentially)
  • Pathology: bilateral mammillary body and medial thalamic nuclei damage — these are key nodes in the Papez circuit (hippocampus → fornix → mammillary bodies → mammillothalamic tract → anterior thalamus → cingulate cortex → hippocampus), which is the circuit for memory consolidation
  • Largely irreversible — only ~20% show significant recovery even with thiamine supplementation

  • Pathogenesis: nutritional deficiency + direct neurotoxicity → degeneration of Purkinje cells in cerebellar cortex → vermis atrophy [2]
  • S/S: subacute/chronic onset of ataxic gait followed by other features of truncal ataxia [2]. Heel-shin test is usually abnormal with severe gait disturbances, but finger-nose testing may reveal only mild abnormalities [2] — why? Because the vermis controls midline/truncal coordination (gait, posture), while the lateral cerebellar hemispheres control limb coordination (finger-nose). Alcohol preferentially damages the vermis.
  • A midline section of the cerebellum from a non-alcoholic (left) and an alcoholic (right) patient shows atrophy of the folia and widening of the sulci in the anterior superior aspect of the cerebellar vermis in the alcoholic patient [1]
  • Course: stabilises with abstinence, but progresses with continued drinking [2]
  • Dx: clinical + CT/MRI showing cerebellar cortical atrophy especially affecting anterior vermis [2]
  • Mx: cessation of drinking and nutritional supplementation [2]
  • Prevalence: ~50–70% of alcohol abusers have some degree of cognitive deficits [2]
  • Pathophysiology: usually multifactorial — NOT solely attributed to ethanol use [2]
    • Aetiological factors: head injury, vascular changes, direct alcohol neuronal toxicity [2]
    • Light/moderate use may paradoxically lead to ↓ risk of dementia, especially in wine drinkers [2]
  • S/S: cognitive impairment simulating frontal lobe dementia (the frontal lobes are more susceptible to alcohol damage) [2] — executive dysfunction, personality change, disinhibition, impaired planning
  • Alcohol-induced neurological deficit [1]:
    • Impairment in visuospatial processing [1]
    • Memory impairment [1]
    • EEG abnormalities [1]
    • Reduction in cerebral blood flow [1]
    • Reduction in cerebral glucose metabolism [1]
  • Dx: diagnosed ≥ 8 weeks after abstinence, based on multiple criteria (Oslin 1998, DSM-5) [2]
  • Neuroimaging findings [2]:
    • Cerebral cortical atrophy with enlarged lateral ventricles
    • Loss of grey matter in cortical and subcortical areas
    • White matter changes with demyelination on DTI

Alcohol and stroke [1]:

  • Haemorrhagic stroke (15% of all strokes): heavy drinking → ↑ risk [1]
  • Ischaemic stroke (85%): light/moderate drinking → ↓ risk [1]
  • Wine is associated with ↓ risk of stroke, but no such relationship for beer/spirits [2]

Why does heavy drinking increase haemorrhagic stroke risk? Multiple mechanisms: (1) chronic hypertension (alcohol activates the RAAS and sympathetic nervous system); (2) impaired coagulation (hepatic dysfunction → ↓ clotting factors + thrombocytopenia); (3) direct vascular endothelial damage from acetaldehyde.

Why might light/moderate drinking decrease ischaemic stroke risk? (1) ↑ HDL cholesterol; (2) ↓ platelet aggregation; (3) ↓ fibrinogen. However, this is controversial — current WHO guidance (2023) and recent large studies suggest there is no safe level of alcohol for overall health.

  • Symmetric distal sensorimotor polyneuropathy — "stocking-glove" distribution
  • Painful paraesthesiae, burning feet, ↓ ankle jerks, distal sensory loss
  • Mechanism: direct neurotoxicity of ethanol + B-vitamin deficiency (B1, B6, B12) → axonal degeneration ("dying-back" neuropathy — the longest axons are most vulnerable because they depend most on axonal transport, which requires energy/nutrition)
  • Affects up to 50% of chronic alcoholics

  • Rare demyelinating disorder of corpus callosum [2]
  • Pathology: demyelination or necrosis of corpus callosum and adjacent subcortical white matter due to hypo-vitamin B (especially B₁) [2]
  • S/S: usually in 40–60 y/o, with subacute onset of [2]:
    • Frontal syndrome: frontal dementia, personality changes
    • Others: seizures, spasticity, rigidity, paralysis, coma, death
  • Neuroimaging: classically hypodense/vacuolation of corpus callosum with white matter lesions [2]
  • Prognosis: variable — death, demented state, or recovery possible [2]

  • Cause: rapid correction of hyponatraemia in acute intoxication → demyelination of pons [2]
  • S/S: spastic paralysis of 4 limbs, pseudobulbar palsy, personality changes, inappropriate affect, delusions; "locked-in" syndrome in severe cases [2]
  • Prevention: never correct hyponatraemia quicker than ~10 mmol/24h [2]
  • Why the pons? The basis pontis has a unique vascular supply (end-artery territory) and a high density of oligodendrocytes that are vulnerable to osmotic stress. Rapid Na⁺ correction → rapid water efflux from brain cells → oligodendrocyte shrinkage and apoptosis → demyelination

ComplicationMechanismKey FeaturesManagement
B12 deficiency [2]Poor nutrition in chronic alcoholismSubacute combined degeneration of cord, peripheral neuropathy, ataxia, optic atrophy, dementia, depression, psychosis, delirium. Classically loss of ankle jerk (peripheral neuropathy) with ↑ knee jerk (SCD of cord) [2]. Require ~350 pg/mL for proper neurological function cf 200 pg/mL for haematological function [2]IM cyanocobalamin 1 mg daily × 7 → 1 mg weekly × 4 → 1 mg monthly [2]
B3 deficiency (pellagra) [2]Poor nutrition3Ds: dementia, dermatitis, diarrhoea; peripheral neuropathy; psychiatric changes (irritability, apathy, depression, cognitive impairment) [2]Nicotinic acid 50 mg TDS PO [2]
Alcohol-tobacco amblyopia [2]Heavy drinking + smoking → deficiency of thiamine or B12 → optic atrophy [2]↓ VA with central scotoma and loss of colour vision [2]Vitamin B12 supplementation [2]

ComplicationMechanismClinical Significance
Alcoholic liver diseaseSteatosis (↑ NADH → ↓ fatty acid oxidation) → Steatohepatitis (acetaldehyde-protein adducts → immune activation) → Fibrosis → Cirrhosis (stellate cell activation → collagen) → HCCProgressive spectrum; cirrhosis is irreversible; HCC screening needed
Oesophageal varicesCirrhosis → portal hypertension → portosystemic collateral formation at oesophageal submucosal veinsRisk of catastrophic upper GI bleed; mortality ~20% per episode
Mallory-Weiss tearForceful vomiting (common in alcoholics) → mucosal tear at gastro-oesophageal junctionUpper GI bleed; usually self-limiting
Gastritis / PUDDirect mucosal irritation by ethanol; ↑ gastric acid secretion; impaired mucosal defencesEpigastric pain, haematemesis
Acute pancreatitisAlcohol is the 2nd commonest cause (after gallstones in HK). Mechanism: premature activation of pancreatic enzymes + direct acinar cell toxicity by ethanol/acetaldehydeSevere epigastric pain radiating to back; ↑ amylase/lipase
Chronic pancreatitisRepeated inflammation → protein plug formation in ducts → calcification → exocrine/endocrine failureChronic pain, steatorrhoea, diabetes mellitus
MalabsorptionDamaged intestinal mucosa + pancreatic exocrine failure + biliary dysfunctionContributes to all nutritional deficiencies
GI malignanciesAcetaldehyde is a Group 1 carcinogen (IARC) — directly damages DNA and impairs DNA repair↑ Risk of oropharyngeal, laryngeal, oesophageal cancers (synergistic with smoking)

ComplicationMechanismKey Features
Alcoholic cardiomyopathyDirect myocardial toxicity from ethanol and acetaldehyde → myocyte apoptosis → dilated cardiomyopathyProgressive heart failure (dyspnoea, oedema, fatigue); partially reversible with abstinence
Atrial fibrillation ("Holiday Heart")Binge drinking → direct electrophysiological effects on atrial myocytes + autonomic surge (↑ sympathetic, ↓ vagal) → triggered AFOften self-terminating; recurrent if binge pattern continues
HypertensionChronic sympathetic activation + RAAS activation + direct vascular effectsDose-dependent; ↓ with abstinence
Ischaemic heart diseaseComplex relationship — light/moderate drinking may be protective (↑ HDL, ↓ platelet aggregation) but heavy drinking is harmful (hypertension, cardiomyopathy, arrhythmia)J-shaped curve; controversial

ComplicationMechanismKey Features
Macrocytosis without anaemiaDirect toxic effect on erythroblast membranes (↑ membrane fluidity → ↑ cell size) + folate deficiency↑ MCV is often the first clue to occult heavy drinking
Megaloblastic anaemiaFolate deficiency → impaired DNA synthesisMacro-ovalocytes, hypersegmented neutrophils
Sideroblastic anaemiaAlcohol inhibits δ-aminolaevulinic acid synthase (the first enzyme in haem synthesis)Ring sideroblasts on bone marrow
ThrombocytopeniaDirect marrow suppression + hypersplenism (portal hypertension → splenomegaly → sequestration)↑ Bleeding risk; typically corrects with abstinence
Compromised immunityAlcohol impairs neutrophil chemotaxis, phagocytosis, T-cell function, and cytokine production↑ Risk of pneumonia, TB, spontaneous bacterial peritonitis
Zieve syndromeRare triad: haemolytic anaemia + jaundice + hyperlipidaemia in the setting of alcoholic liver diseaseHaemolysis due to altered RBC membrane lipids

ComplicationMechanism
Hypoglycaemia↑ NADH:NAD⁺ ratio → blocked gluconeogenesis [2]
Pseudo-Cushing syndromeChronic alcohol → ↑ CRH and ACTH → ↑ cortisol. Features mimic Cushing's but resolve with abstinence
Electrolyte disturbanceHypoK⁺ (GI losses + renal wasting), hypoNa⁺ (beer potomania, SIADH), hypoMg²⁺ (poor intake + renal wasting), hypoPO₄³⁻ (refeeding shifts, poor intake) [2]
Hypogonadism↑ Aromatisation of androgens → oestrogens in cirrhotic liver + direct gonadal toxicity → gynaecomastia, testicular atrophy, impotence, infertility [2]
Alcoholic ketoacidosisBinge → fasting → ↑ NADH + ↑ free fatty acids → ↑ ketone bodies

Fetal Alcohol Syndrome (FAS) [1]:

  • Heavy drinking → 30% risk [1]
  • 1–4 per 1000 live births in the US [1]
  • Microcephaly [1]
    • Agenesis of corpus callosum [1]
    • Cerebellar hypoplasia [1]
  • Most common cause of preventable mental retardation [1]
  • Low birth weight [1]
  • Facial dysmorphology [1] — smooth philtrum, thin upper lip, short palpebral fissures (the classic "FAS facies")
  • Growth retardation [1]

Why does alcohol cause these effects? Ethanol freely crosses the placenta and the fetal BBB. The fetus has very low ADH and ALDH activity → cannot metabolise ethanol efficiently → prolonged exposure. Ethanol disrupts neural crest cell migration (→ facial features), neuronal proliferation and migration (→ microcephaly, corpus callosum agenesis), and synaptogenesis (→ intellectual disability). There is no known safe level of alcohol in pregnancy.


ComplicationMechanism
ImpotencePeripheral neuropathy (pelvic autonomic) + direct gonadal toxicity + hypogonadism
Hypogonadism and infertility↓ Testosterone (direct toxic effect on Leydig cells + ↑ aromatisation) → ↓ spermatogenesis
↑ Breast cancer riskAlcohol ↑ oestrogen levels; acetaldehyde is a carcinogen; alcohol impairs folate metabolism (folate is needed for DNA repair)

I. Psychiatric Complications [1][2]

Psychiatric comorbidity in alcoholism is very common — lifetime diagnosis occurs in 55% of alcoholics [2]

  • Moderate or heavy alcohol use [1]
  • Major depression or mania [1]
  • Persist for up to 4 weeks after abstinence [1]
  • Clears up on stopping alcohol [1]
  • 4× risk of major depression in patients with history of alcohol dependence [2]

  • Symptoms occur while patient on heavy alcohol consumption [1]
  • Symptoms subside gradually on abstinence, but may persist up to 6 months [1]
  • Generalised anxiety disorders / Panic disorder / Phobic anxiety disorders / Social phobia / Obsessive compulsive disorder / PTSD [1]
  • Must be distinguished from alcohol withdrawal syndrome [1]

  • Chronic heavy drinkers [1]
  • Auditory hallucinations [1]
  • In clear consciousness [1]
  • Distressing in content [1]
  • Some develop schizophrenia, some remit after stopping alcohol use [1]
  • Treatment with antipsychotics and advice to abstain from alcohol [1]
  • Differentiate from delirium tremens: reduction in alcohol intake, clouded sensorium, visual hallucinations [1]

  • Chronic heavy drinking [1]
  • Clear sensorium [1]
  • Schizophrenia-like syndrome [1]
  • Remission on stopping alcohol [1]
  • Recur with relapse of alcoholism [1]

  • Delusional disorder with theme of partner's infidelity [2]
  • Most commonly in men [2]
  • Risk of violence: 56% of men and 43% of women [2]
  • Mx: antipsychotics [2]

Sleep pattern in alcohol-dependent patientSleep changes in abstinent alcoholics
↓ Sleep latency [2]↑ Sleep latency [2]
Rebound insomnia [2]Light and fragmented sleep [2]
Repeated awakening [2]↓ Overall sleep time with ↓ amount of deep sleep [2]
Tolerance with ↓ hypnotic effects by alcohol [2]These changes persist for 2 years after abstinence [2]

Why does alcohol disrupt sleep? Acutely, alcohol promotes sleep onset (GABA potentiation → sedation → ↓ sleep latency), but it suppresses REM sleep and disrupts sleep architecture in the second half of the night (as BAC falls, a "mini-withdrawal" hyperexcitability occurs → awakenings, vivid dreams). Chronically, tolerance develops to the sedative effect, but the sleep-disrupting effects persist. After abstinence, the upregulated excitatory systems take a very long time to re-equilibrate — hence the 2-year persistence.

Alcohol and suicide [1]:

  • 7% of alcohol abusers die of suicide [1]
  • Alcoholism is a factor in 30% of all completed suicides [1]
  • 50% of suicide attempts have consumed alcohol at the time of the attempt [1]
  • 96% of alcoholics who die by suicide continue alcohol use up to the end of their lives [1]

Why is alcohol so strongly linked to suicide? Multiple convergent mechanisms:

  1. Acute disinhibition — alcohol removes inhibitory control over impulsive suicidal acts (prefrontal cortex depression)
  2. Chronic depression — alcohol-induced mood disorder; hopelessness
  3. Social isolation — progressive loss of relationships, employment, purpose
  4. Comorbid psychiatric disorders — depression (40%), anxiety (32%), personality disorders
  5. Means availability — intoxicated individuals are more likely to act on suicidal thoughts with available means
  6. Cognitive constriction — alcohol narrows attentional focus to immediate distress, reducing ability to see alternative solutions

Alcohol and Suicide — Must Know Statistics

These lecture statistics are extremely high-yield for exams: 7% of alcohol abusers die by suicide; 30% of completed suicides involve alcoholism; 50% of suicide attempters had consumed alcohol at the time. Always assess suicide risk in every patient with alcohol misuse.


ComplicationMechanism
Poor functioningCognitive impairment, withdrawal symptoms, preoccupation with drinking
Financial issuesMoney spent on alcohol; job loss from impaired performance
Interpersonal problemsDisinhibited behaviour, domestic violence, relationship breakdown
Road traffic accidentsImpaired judgement, coordination, reaction time
Legal problemsDrink-driving, assault, public order offences

Comorbid psychiatric disorders in alcoholism [1]:

  • Antisocial personality disorders: 80% [1]
  • Bipolar I disorder: 60% [1]
  • Schizophrenia: 30% [1]
  • Drug addiction: 20% [1]
  • Anxiety disorders — social phobia, panic disorder [1]

When schizophrenia is comorbid [1]:

  • Alcohol decreases feeling of isolation [1]
  • Temporarily reduces symptoms of anxiety / depression / insomnia [1]
  • BUT: increases psychotic symptoms and mood swings [1]
  • Disruptive behaviour, suicide, treatment non-compliance, drug abuse, poor clinical outcome [1]
  • Drug accumulation due to hepatic damage [1]

Why Hepatic Damage Matters for Psychiatric Medications

Chronic alcoholic liver disease impairs hepatic metabolism of psychiatric medications (most antipsychotics and antidepressants undergo hepatic phase I oxidation via CYP enzymes). Reduced hepatic clearance → drug accumulation → toxicity at standard doses. This is why doses of psychotropics often need to be reduced in alcoholic patients with liver disease, and why drug levels and LFTs must be monitored closely.


SystemComplications
Acute neurologicalIntoxication ± blackout, traumatic brain injury, withdrawal syndrome (hallucinosis, seizures, DT), central pontine myelinolysis [2]
Chronic neurologicalWernicke-Korsakoff syndrome, cerebellar (vermis) degeneration, alcohol-related dementia, ↑ risk of haemorrhagic stroke, peripheral and optic neuropathy, Marchiafava-Bignami syndrome [2]
GastrointestinalAlcoholic liver disease (steatosis → hepatitis → cirrhosis → HCC), acute and chronic pancreatitis, oesophagitis, Mallory-Weiss, PUD/gastritis, malabsorption, GI malignancies [2]
CardiovascularIHD, dilated cardiomyopathy, AF, hypertension [2]
HaematologicalCompromised immunity, macrocytosis, Zieve syndrome [2]
Endocrine/MetabolicHypoglycaemia, pseudo-Cushing's, electrolyte disturbance (hypoK, hypoNa, hypoMg, hypoPO₄), vitamin deficiencies (B1, B3, B6, B12, folate), alcoholic ketoacidosis [2]
MusculoskeletalAcute and chronic myopathy, osteoporosis + fractures [2]
ReproductiveImpotence, hypogonadism/infertility, ↑ breast CA risk [2]
FetalIUGR, neurodevelopmental disorder, fetal alcohol syndrome [1][2]
PsychiatricDependence, personality deterioration, mood/anxiety disorders, psychotic disorders, sleep disorders, Othello syndrome, suicide [1][2]
PsychosocialPoor functioning, financial issues, interpersonal problems, RTAs, legal problems [2]

High Yield Summary

Complications of Alcohol Misuse — Key Exam Points:

  1. Wernicke encephalopathy: Only 20% detected in life; 20% mortality; 84% progress to Korsakoff. Triad = confusion + ophthalmoplegia + ataxia. IV thiamine 500 mg TDS × 3 days. Medical emergency.
  2. Korsakoff syndrome: Anterograde amnesia + confabulation. Mammillary body and medial thalamic damage. Largely irreversible.
  3. "Front, Back, Centre": Frontal lobe → dementia; Cerebellar vermis → ataxia; Corpus callosum → Marchiafava-Bignami.
  4. 6 causes of confusion in alcoholism: Intoxication, DT, Head injury, Metabolic disturbance (hypoglycaemia), Hepatic encephalopathy, Wernicke encephalopathy.
  5. Fetal Alcohol Syndrome: Most common cause of preventable mental retardation. Microcephaly, facial dysmorphology, growth retardation, agenesis of corpus callosum, cerebellar hypoplasia. 30% risk with heavy drinking.
  6. Alcohol and Suicide: 7% of alcohol abusers die by suicide; 30% of completed suicides involve alcohol; 50% of attempters consumed alcohol at the time.
  7. AST:ALT > 2:1 in alcoholic liver disease. ↑GGT (non-specific), ↑MCV (direct toxicity + folate deficiency), ↑CDT (most specific).
  8. Central pontine myelinolysis: Never correct Na⁺ faster than 10 mmol/24h.
  9. Alcohol-induced neurological deficit: Impaired visuospatial processing, memory impairment, EEG abnormalities, reduced cerebral blood flow and glucose metabolism.
  10. Psychiatric comorbidity in 55% of alcoholics; depression most common (40%); always assess suicide risk.
  11. Sleep disruption persists for 2 years after abstinence.
  12. Stroke: Light/moderate → ↓ ischaemic stroke risk (controversial); Heavy → ↑ haemorrhagic stroke risk.

Active Recall - Complications of Alcohol Misuse

References

[1] Lecture slides: GC 161. Alcohol and the Brain From Psychiatric to Neuropsychiatric Perspectives.pdf (p12, p14, p24, p28, p34, p36–44, p48) [2] Senior notes: ryanho-psych.md (sections 5.1, 5.1.1, 5.1.2; pages 96–110)

High Yield Summary

Key Concepts:

  1. 1 unit in HK = 10g pure ethanol; safe limits = 2 units/day (M), 1 unit/day (F)
  2. Neuropharmacology: Alcohol = GABA-A potentiator + NMDA inhibitor + ↑ mesolimbic DA. Chronic use → GABA-A downregulation + NMDA upregulation. Withdrawal = excitotoxic state.
  3. ALDH2*2 mutation is common in Asians → protective against alcoholism (flush reaction) but ↑ cancer risk if they do drink
  4. Cloninger Type 1 (later onset, both sexes, mild genetics) vs Type 2 (early onset, male, strong genetics, antisocial)
  5. Withdrawal timeline: Tremor (6–12h) → Hallucinosis (12–24h) → Seizures (12–48h) → DT (48–72h). Each successive withdrawal is worse (kindling).
  6. Wernicke triad: Confusion + Ophthalmoplegia + Ataxia. Give IV thiamine BEFORE or WITH glucose. Only 10% have full triad — maintain a low threshold.
  7. Korsakoff: Anterograde amnesia + confabulation. Mamillary bodies + medial thalamus damage. Largely irreversible.
  8. 6 causes of confusion in alcoholism: Intoxication, Withdrawal/DT, Wernicke, Hepatic encephalopathy, Hypoglycaemia, Subdural haematoma
  9. Psychiatric comorbidity in 55% of alcoholics: Depression (40%), Bipolar I (60% of bipolar patients), Antisocial PD (80% of ASPD patients), Schizophrenia (30%), Anxiety (32%)
  10. Diagnosing comorbid psych disorder: psychiatric disorder before alcohol onset, persistent symptoms during ≥ 4 weeks alcohol-free, FHx of psychiatric disorder
  11. Screening: AUDIT (best — ↑ sensitivity + specificity, 10-item WHO tool) > CAGE (↑ sensitivity only)
  12. Lab markers: ↑GGT (70%, non-specific), ↑MCV (60%, weeks to normalise), ↑CDT (most specific)

High Yield Summary

Differential Diagnosis of Alcohol-related Disorders — Key Exam Points:

  1. 6 causes of confusion in alcoholism (must memorise): Intoxication, DT, Head injury/subdural, Metabolic disturbances (hypoglycaemia), Hepatic encephalopathy, Wernicke encephalopathy
  2. Alcoholic hallucinosis vs DT: Hallucinosis = auditory hallucinations + clear sensorium; DT = visual hallucinations + clouded sensorium + autonomic storm
  3. Alcohol-induced vs primary psychiatric disorder: Use the 3 criteria — (i) psychiatric disorder before alcohol onset, (ii) persistent symptoms > 4 weeks of abstinence, (iii) FHx of psychiatric disorder
  4. Alcohol-induced mood disorder clears within 4 weeks of abstinence; alcohol-induced anxiety may persist up to 6 months
  5. The relationship is bidirectional with confounding factors — alcohol can cause, result from, or co-occur with psychiatric disorders
  6. Othello syndrome (morbid jealousy): a specific alcohol-related delusional disorder — beware risk of violence (56% of men)
  7. Always check: H'stix, BAC, NH₃, CT head, electrolytes, and timeline from last drink in any confused alcoholic

High Yield Summary

Diagnostic Criteria and Investigations — Key Exam Points:

  1. DSM-5 AUD: ≥ 2 of 11 criteria in 12 months. Mild (2–3), Moderate (4–5), Severe (6+). Single unified diagnosis replacing the old abuse/dependence dichotomy.
  2. ICD-10 Dependence: ≥ 3 of 6 criteria (compulsion, impaired control, withdrawal, tolerance, neglect, persistent use despite harm).
  3. Edwards & Gross: 7 elements — narrowing of repertoire, increased salience, tolerance, withdrawal, relief drinking, subjective compulsion, reinstatement after abstinence.
  4. DSM-5 Intoxication: Recent ingestion + behavioural change + ≥ 1 of 6 signs (slurred speech, incoordination, unsteady gait, nystagmus, attention/memory impairment, stupor/coma) + not better explained by another condition.
  5. Screening: AUDIT is best (10-item WHO tool, ↑ sens + spec, ≥ 8 screen positive). CAGE is quick but modest specificity.
  6. SADQ > 30 → inpatient detox. CIWA-Ar: < 10 very mild, 10–15 mild, 16–20 moderate, > 20 severe; guides symptom-triggered BZD therapy (start at ≥ 8).
  7. Lab biomarkers: ↑ GGT (70% sens, non-specific), ↑ MCV (60% sens, weeks to normalise), ↑ CDT (most specific). AST:ALT > 2:1 classic for alcoholic liver disease.
  8. Alcohol-induced vs comorbid psych disorder: Use 3 criteria — (i) psych disorder before alcohol, (ii) persistent symptoms > 4wk abstinence, (iii) FHx of psych disorder.
  9. Always get: H'stix, FBC, LFT, RFT, Mg, PO₄, coag, urine tox. CT head if confused/seizure/focal signs.

High Yield Summary

Management of Alcohol-related Disorders — Key Exam Points:

  1. Acute intoxication: Supportive — ABC, IV fluids, H'stix, thiamine (before or with glucose), BZD/FGA if agitated. No antidote.
  2. Withdrawal: BZDs are cornerstone — prefer long-acting (chlordiazepoxide, diazepam); use oxazepam/lorazepam in liver disease. Symptom-triggered dosing (CIWA-Ar ≥ 8) preferred over fixed-schedule.
  3. DT: Medical emergency (5% mortality). IV BZD in decreasing dosage, anticonvulsants (carbamazepine), parenteral thiamine, neuroleptics for agitation, fluid/electrolyte balance. Barbiturates/propofol for refractory cases.
  4. Wernicke: Medical emergency (20% mortality). IV thiamine 500 mg TDS × 3 days. Only 20% detected in life → low threshold for treatment. 84% progress to Korsakoff if untreated.
  5. Inpatient detox indications: SADQ > 30, Hx seizures/DT, > 30 units/day, concurrent BZD misuse, significant comorbidity.
  6. NICE staged approach: At-risk → brief intervention. Mild dependence → psychotherapy. Moderate/severe → acamprosate or naltrexone + psychotherapy.
  7. Relapse prevention drugs: Acamprosate (↓ glutamate, safe in liver disease), Naltrexone (blocks opioid reward, CI in opioid use), Disulfiram (ALDH inhibitor → aversive reaction, needs supervision), Nalmefene (PRN harm reduction).
  8. Psychosocial: MI (assess readiness, build motivation), CBT (identify triggers, develop coping), AA (12-step peer support), Brief intervention (at-risk drinkers).
  9. Treatment goals: Controlled drinking (early, non-dependent) vs Total abstinence (dependent, failed controlled drinking).
  10. Always treat alcohol alongside comorbid psychiatric disorders — response to psych treatment is much less likely if alcoholism is not addressed.

High Yield Summary

Complications of Alcohol Misuse — Key Exam Points:

  1. Wernicke encephalopathy: Only 20% detected in life; 20% mortality; 84% progress to Korsakoff. Triad = confusion + ophthalmoplegia + ataxia. IV thiamine 500 mg TDS × 3 days. Medical emergency.
  2. Korsakoff syndrome: Anterograde amnesia + confabulation. Mammillary body and medial thalamic damage. Largely irreversible.
  3. "Front, Back, Centre": Frontal lobe → dementia; Cerebellar vermis → ataxia; Corpus callosum → Marchiafava-Bignami.
  4. 6 causes of confusion in alcoholism: Intoxication, DT, Head injury, Metabolic disturbance (hypoglycaemia), Hepatic encephalopathy, Wernicke encephalopathy.
  5. Fetal Alcohol Syndrome: Most common cause of preventable mental retardation. Microcephaly, facial dysmorphology, growth retardation, agenesis of corpus callosum, cerebellar hypoplasia. 30% risk with heavy drinking.
  6. Alcohol and Suicide: 7% of alcohol abusers die by suicide; 30% of completed suicides involve alcohol; 50% of attempters consumed alcohol at the time.
  7. AST:ALT > 2:1 in alcoholic liver disease. ↑GGT (non-specific), ↑MCV (direct toxicity + folate deficiency), ↑CDT (most specific).
  8. Central pontine myelinolysis: Never correct Na⁺ faster than 10 mmol/24h.
  9. Alcohol-induced neurological deficit: Impaired visuospatial processing, memory impairment, EEG abnormalities, reduced cerebral blood flow and glucose metabolism.
  10. Psychiatric comorbidity in 55% of alcoholics; depression most common (40%); always assess suicide risk.
  11. Sleep disruption persists for 2 years after abstinence.
  12. Stroke: Light/moderate → ↓ ischaemic stroke risk (controversial); Heavy → ↑ haemorrhagic stroke risk.

On this page

No Headings